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This dissertation focuses on systematic studies using microfluidic platforms for sensing 
of microorganisms, including whole microorganism separation, and nucleic acid and antibody 
detection. These devices have been constructed, validated, and applied to clinically related 
samples under the guidance of point-of-care criteria. Specifically, an inertial microfluidic device 
designed for the enrichment of micron and submicron-sized particles and bioparticles with high 
throughput has been thoroughly investigated (Chapters 2 and 3). To directly detect and identify 
nucleic acids and anti-pathogen antibodies in an ultra-sensitive manner, capacitive-based affinity 
biosensors have been extensively studied (Chapters 4 and 5). Continued development of these 
point-of-need platforms has the potential to greatly increase the capacity of public health 
agencies in both developed and developing countries in order to readily and rapidly monitor and 
diagnose emerging infectious diseases of global significance. 
The ability to study individual bacteria or subcellular organelles using inertial 
microfluidics is still nascent. This is due, in no small part, to the significant challenges associated 
with concentrating and separating specific sizes of micrometer and sub‐micrometer bioparticles 
in a microfluidic format. In Chapter 2, using a rigid polymeric microfluidic network with 
optimized microchannel geometry dimensions, it is demonstrated that 2 µm, and even 
sub‐micrometer, particles can be continuously and accurately focused to stable equilibrium 
positions within the channels. Suspensions have been processed at flow rates up to 1400 µL 
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min−1 in an ultrashort 4 mm working channel length. A wide range of suspension 
concentrations—from 0.01 to 1 v/v%—have been systematically investigated, with yields greater 
than 97%, demonstrating the potential of this technology for large‐scale implementation. 
Additionally, the ability of this chip to separate micrometer‐ and sub‐micrometer‐sized particles 
and to focus bioparticles (cyanobacteria) has been demonstrated. This study pushes the 
microfluidic inertial focusing particle range down to sub‐micrometer length scales, enabling 
novel routes for investigation of individual microorganisms and subcellular organelles.  
Next in Chapter 3, the inertial microfluidics built in Chapter 2 for micron-sized particles 
has been applied for concentration of Cyanobacterium Synechocystis sp. PCC 6803 with a 
typical size of 2 µm. The materials used in the new device were chosen with an eye toward low-
cost, large-scale commercial manufacture. The operating parameters for inertial focusing of the 
cyanobacteria suspension have been optimized to achieve high-throughput and high-efficiency 
concentration. The maximum recovery efficiency achieved in a single microchannel device is 
98.4 ± 0.2% (mean ± standard deviation). For those conditions, initial results yield a 
concentration factor of 3.28 for a single pass, which is 98.5% of the maximum possible value for 
the current design. In addition, the calculated power consumption is less than or equal to that of 
traditional enrichment methods for a wide range of concentration factors. It is anticipated that 
this highly parallelizable, robust approach of enrichment will be economically feasible for 
concentrating microorganisms. 
In Chapter 4, a label-free affinity-based capacitive biosensor using interdigitated 
electrodes has been investigated for ultrasensitive nucleic acid detection. Using an optimized 
process of DNA probe preparation to minimize the effect of contaminants present in commercial 
thiolated DNA probe, the electrode surface was functionalized with 24-nucleotide DNA probes 
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based on a complementary West Nile virus sequence (Kunjin strain). The biosensor has the 
ability to detect complementary DNA fragments with a detection limit down to 20 DNA target 
molecules (1.5 aM range), making it suitable for a practical point-of-care (POC) platform for low 
target count clinical applications without the need for amplification. The reproducibility of the 
biosensor detection was improved with efficient covalent immobilization of purified single-
stranded DNA probe oligomers on cleaned gold microelectrodes. In addition to the low detection 
limit, the biosensor showed a dynamic range of detection from 1 µL−1 to 105 µL−1 target 
molecules (20 to 2 million targets), making it suitable for sample analysis in a typical clinical 
application environment. The binding results for capacitive detection were validated using 
fluorescent probe and target oligomers. Overall, our findings suggest that these ultrasensitive 
sensor platforms have the potential to be used as a reliable, sensitive, and in-expensive diagnostic 
tool for detection of pathogen-specific nucleic acid and immune response at the point-of-care.    
Detection of viral infection is commonly performed using serological techniques such as 
the enzyme-linked immuno-sorbent assay (ELISA) to detect virus-specific antibody responses. 
Such assays may also be used to determine the phase of infection based on antibody isotype 
prevalence. However, ELISAs demonstrate limited sensitivity and are difficult to perform at the 
point of care. In Chapter 4, a novel technique for label-free, rapid detection of ultra-low 
concentrations of virus specific antibodies is presented.  A simple and robust capacitive 
biosensor based on Zika or Chikungunya antigen-coated microwires has been developed. With 
little discernable nonspecific binding, the sensor can detect as few as 10 antigen-specific 
antibody molecules in a small volume, and do so within minutes.  The system can also be used to 
rapidly and specifically determine the isotype of the antigen-specific antibodies.  Finally, the 
results of clinical related sample demonstrated that anti-Zika virus antibody can be sensitively 
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and specifically detected in dilute serum of immune mouse and can be accurately isotyped using 
the sensor. 
Lastly in Chapter 6, the most interesting future directions, in my viewpoint, stem out of 
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Microorganisms include viruses, bacteria, fungi, protozoa, helminthes etc., which can be 
transferred from one host to another through air, body fluids, food, and water [1]. Any 
microorganism capable of causing disease, and that cause public transmission and economic 
losses is known as a pathogenic microorganism [2]. Based on a World Health Organization 
(WHO) report, pathogenic microorganism-induced infectious diseases are the second leading 
cause of death throughout the world [3]. For example, lower respiratory tract infections, diarrheal 
diseases, tuberculosis and HIV/AIDS resulted in 7.1 million deaths worldwide in 2015 [3]. In 
particular, the unprecedented growth in international travel and trade is making the spread of 
infectious disease more evident as pandemic risks and outbreaks in the era of globalization [4]. 
Thus, effective and rapid microbial detection is an essential prerequisite for diagnosis of 
microorganisms and treatment of disease. In the developed world, the standard and conventional 
detection methods are typically conducted in high-resource setting laboratories by trained 
technicians, and are often laborious, time-consuming and costly. Despite the significant advances 
in improved diagnostic technologies in developed countries, safety issues related to food 
industries, pathogen outbreaks and sexually transmitted diseases remain to be addressed. For 
instance, food-borne pathogens were the cause of more than 50 million illnesses reported in the 
USA alone in 2011 [5]. The situation is even more severe in developing countries, where 
centralized laboratories for diagnostics and treatments are usually lacking. Indeed, half of the 
mortality in these countries is due to infectious diseases [6]. Bringing diagnostics to the point of 
need could potentially allow preliminary self-screening, sorting and employment to supplement 
the basic medical equipment available in third-world nations [4]. In summary, the timely, 
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effective and low-cost detection of microorganisms, especially point-of-care sensing of 
pathogenic microbes, remains a pressing issue in a wide array of fields ranging from infectious 
disease diagnostics [7], food safety [8], drug discovery [9] and clinical research [10]. 
1.2 Conventional and Standard Methods of Microorganism Detection  
The established and standard methods of microorganism detection include microscopy, 
the culture and colony counting method, polymerase chain reaction (PCR) amplification, and 
immunoassay [11]. These methods depend on the identification of unique microbiological and 
biochemical components, and are often combined to yield a more robust result. 
Microscopy is a widely used and versatile technique to visualize pathogens which cannot 
be seen with naked eyes [12], but it is limited in terms of its sensitivity and relatively subjective 
interpretation of results.  
The culturing technique is the oldest microbiological method of detection and remains a 
standard diagnosis for bacterial identification. This process consists of selective plating, pre-
enrichment, selective enrichment, and identification [13], which usually takes 2-3 days for initial 
results and up to 7-10 days for confirmation [14]. Its main drawbacks are extremely long 
diagnostic time, labor intensive procedures, high risk of contamination and the requirement of 
skilled personal to interpret the results [14].  
Polymerase chain reaction (PCR) is a nucleic acid amplification technology, which is 
able to amplify a specific segment of a nucleic acid by cycling through three temperature steps 
and create millions of copies within hours [15]. Firstly, the target double-stranded DNA is 
denatured at high temperature into two single-stranded DNAs. Then, the specific primers will 
anneal to the DNA strands, which is followed by the polymerization process in the presence of 
deoxyribonucleotides and a thermostable DNA polymerase. The presence of PCR amplification 
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products are visualized on an electrophoresis gel [14]. PCR is the most widely adopted method 
of detection because it detects the nucleic acid by amplifying the DNA/RNA molecules rather 
than by amplifying the signal of the products, thus it is less prone to produce false-positive 
results [14]. Although PCR offers the advantages of specificity, sensitivity and the capacity to 
detect relatively small numbers of target nucleic acid in samples, it still requires DNA extraction 
from microbial cells, trained personal to operate and interpret the results, and relative long assay 
time on the order of hours [16], which limits its point-of-care applications.  
The antigen-antibody binding based immunoassay is one of the mainstays of pathogen 
detection, which however requires purified antibody and has the risk of false positive results due 
to cross-reactivity [17]. The types of antibodies used for immunodetection include monoclonal, 
polyclonal and recombinant antibodies [14]. Monoclonal antibodies are able to increase the 
detection specificity compared to their polyclonal counterparts, while polyclonal antibodies can 
be produced more quickly and more cost effectively. Recombinant antibodies bridge this gap 
since they can be raised with high specificity in short time from bacteria [14].  Examples of 
immunoassays include the enzyme immunoassay (EIA), Enzyme-linked immunosorbent assay 
(ELISA), Enzyme-linked fluorescent assay (ELFA), immunomagnetic separation and western 
blot [14].  
Overall, the established standard methods for microorganism detection are often labor-
intensive, time-consuming and require centralized facilities and experienced personnel [18]. 
Ideal pathogen detection methods for point-of-care applications should not only have sensitivity 
and specificity comparable to established standard methods but also be cost-effective, fast and 
easy to operate and interpret [19]. In addition, the platform should also be stable and robust 
under a wide range of environmental conditions, low-cost and portable, preferably handheld and 
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disposable [15]. The ability to perform multiplex tests is another important prerequisite, 
especially for pathogens causing infections with similar symptoms [15].  
1.3 Microfluidic Units and biosensors for Microbial Detection 
Technologies such as microfluidics and biosensors are promising approaches to meet the 
aforementioned requirements as point-of-care diagnostic platforms [4]. Microfluidics is the 
science of manipulating and controlling fluids and particles at micron and submicron scales and 
the technology associated with the development of methods and devices to undertake such tasks 
[4]. Microfluidics is able to significantly reduce the sample volume needed, and is good at 
processing small volumes of complex fluids in a timely and effectively manner without the need 
for trained technicians and centralized facilities. Microfluidics facilitates the development of 
disposable chips that can be easily integrated with other devices. In addition, the standard 
fabrication technology of lithography is fast and straightforward. Other fabrication techniques 
such as hot embossing and injection molding of thermoplastics (e.g., polymethylmethacrylate, 
polystyrene and polycarbonate) have been also used [4]. Microfluidic systems fabricated on 
paper offer a cheap and biodegradable alternative for simple point-of-care diagnostic 
applications [4]. In the past several decades, the field of microfluidics has grown tremendously, 
sustained by its promises to revolutionize conventional laboratory handling, processing and 
analytical techniques [4]. This unique set of capabilities is exactly what is needed for point-of-
care diagnostic systems [15].  
Similar to microfluidics, biosensors also draw a lot of interest for point-of-care detection 
due to their comparable specificity and sensitivity with established standard methods yet much 
faster detection times. Biosensors have been defined as analytical devices incorporating 
biological materials integrated within a physicochemical transducer or transducing microsystem, 
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which could be optical, electrochemical, thermometric, piezoelectric, magnetic or 
micromechanical [18].  Biosensors usually consist of two main components: a bioreceptor or a 
biorecognition element to recognize the target analyte, and a transducer to convert a recognition 
event into a measurable electrical or optical signal [14].  
In general, the microsystems used to detect microorganisms can be further divided into 
three broad categories, namely through conducting whole-cell microorganisms separations, the 
sensing of genetic materials/nucleic acids, e.g., DNA or RNA, and detection of metabolite 
products via protein-based assays, e.g., viral structural protein [4]. These three broad categories 
will be briefly reviewed in the following sections.  
1.3.1 Whole Cell Based Microbial Separation or Concentration 
In real-world clinical samples, the concentration of whole microorganism cells is often 
very low and their sizes quite small—from several microns to tens of nanometers—which makes 
pathogen detection extremely challenging [20]. For example, even when patients have developed 
clear clinical symptoms of sepsis, there may be only 1 to 30 colony forming units/mL, and most 
bacteria range from 0.2 – 2.0 µm in diameter [21]. In addition, there are invariably a large 
number of interfering or confounding species present in the samples, such as the billions of blood 
cells mixed with these bacteria. Therefore, isolating or concentrating target microorganisms prior 
to detection is one critical step in order to realize an effective diagnostic. Many microfluidic 
devices have been developed to enrich microorganisms from air [22], water [23], and clinical 
samples [24]. The methods for microbial enrichment can be generally classified as physical or 
biochemical. With higher potential for point-of-care applications, the physical approaches are the 
focus of this dissertation. Several promising physical methods are introduced as follows.  
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There are three strategies usually exploited in the physical separation methods, namely 
properties of pathogen, the special designs of microchannels and external fields [1], which can be 
further classified broadly into passive and active techniques. Passive techniques take advantage 
of the microchannel structures, the flow field and the interactions between the pathogen particles 
[25]. Example techniques includes filtration, pinched flow fractionation, deterministic lateral 
displacement and inertial focusing microfluidics.  
Filtration is a straightforward separation method that utilizes membrane [26], weir [27], 
pillar [28] and cross flow [29] to sort particles/bioparticles based on their sizes when flow passes 
through. Filtration-based microfluidics are widely used to separate biological samples, such as 
blood samples [30] and urine samples [26]. However, the major problem of these methods is the 
clogging of particles on the filter faces or between pillars and weirs. Cross-flow filtration is 
similar in terms of operation but different in the flow direction, which is perpendicular to the 
micropost array and is able to alleviate the particle accumulation in some extent. But the 
separation efficiency of the cross-flow filtration is usually limited, because the particles/cells are 
mostly distributed across the microchannels and only the part of particles that reaches the 
filtering region can be sorted [29]. 
Pinched flow fractionation (PFF) is another technique among the passive sorting 
methods, which is able to separate particles based on their sizes using the intrinsic property of 
laminar flow in a continuous manner [31]. In pinched flow fractionation, two microchannels are 
aligned to a wider channel with a pinched segment. One of the microchannels is continuously 
introduced with particle suspension while the other microchannel has particle-free flow at higher 
flow rates. The wall of the pinch segment induces forces toward the center of the channel in 
proportion to the particle sizes. These forces shift the flow profile and lead to separations of the 
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particles perpendicular to the flow direction based on their sizes [32]. Therefore, smaller 
particles are close to the wall of the broadened segment while large particles are near the 
centerline of this segment. Then the separated particles can be collected independently by a set of 
collecting branches [32]. In the symmetrical design of outlet branches, particles with diameters 
less than the width of the pinched section cannot be separated [33]. The asymmetrically arranged 
multiple branches enable the separations of particles one order of magnitude smaller compared to 
the symmetrical design. This asymmetrical design was shown to be able to separate a mixture of 
particles with different diameters ranging from 1.0 to 5.0 µm [34]. But, 1 µm appears to be the 
smallest particle size that can be sorted by pinched flow fractionation as reported in published 
studies, which is around the size of bacteria but still much bigger than any viruses. Therefore, 
PFF can be applied to accurately separate one bacterium from other bacteria based on their 
differences in sizes, which is difficult to achieve using other methods such as filtration 
mentioned above.  
Compared to pinched flow fractionation, the deterministic lateral displacement (DLD) 
method provides a much better separation resolution, which can be as small as 800 nm [35]. The 
DLD utilizes posts in specific arrangements in microchannels to guide the pathways of the 
particles. Each sequential row of posts shifts laterally at a specified angle, which results in 
known paths of flow. Then a particle moves to the streamline that aligns with its diameter, and 
particles with different sizes can be separated from each other along the array of posts [36]. This 
technology has been used to separate millimeter [37], micrometer [38] and even sub-micrometer 
[39] sized particles, and has been applied for whole blood components [38],  blood plasma with 
no dilution [38], and bacterial artificial chromosome separation [39]. As reported, the smallest 
size of microspheres separated is 0.8 µm [39]. The size-based separation of bacteria can therefore 
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be realized using this technique. With advances in nanofabrication, the gap size between posts 
could be further reduced and these improved devices could, in principle, be used to fractionate 
even smaller biological samples, such as virus particles. However, the very low throughput (0.01 
µL/min  [40]), requirements for high precision fabrication, and pillar clogging are the major 
limitations of this approach for broader applications.  
As one of the passive sorting methods, inertial focusing microfluidics is not only able to 
separate particles/bioparticles based on their size differences, but also to focus the particles into 
single or multiple particle trains during the same process, which makes inertial focusing highly 
promising for novel applications such as miniaturized flow cytometry and digital microfluidics-
based single-cell analysis. The inertial focusing phenomenon arises from lateral forces exerted 
on particles in a dilute suspension as they are transported in a non-uniform velocity profile under 
finite Reynolds number, laminar conditions. The equilibrium migration location of particles 
depends on a number of factors, including the ratio of the particle size to the channel dimensions, 
and the Reynolds number , which is a dimensionless parameter describing the ratio of inertial 
forces to viscous forces [41]. In laminar channel or tube flow, each particle experiences a force 
associated with the parabolic velocity profile. This force, the shear gradient lift force ( ), 
pushes particles away from channel centerline. At the same time, channel wall induces a wall-
effect lift force ( ), which moves the particles away from the channel or tube wall [42]. The 
net lift force ( ) in a rectangular channel can be expressed as [43] 
 
where ρ is the fluid density,  is the maximum channel velocity,  is the particle 
diameter,  is the lift coefficient, and  is the hydraulic diameter, where  
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and  are the height and width of the channel cross-section, respectively. Application of inertial 
focusing devices mainly focus on precise manipulation of erythrocyte-sized cell suspensions for 
a number of applications in clinical diagnostics [43]–[46]. Inertial focusing based microfluidics 
possesses very high throughput (1500 µL/min [47]), very high separation efficiency and simple 
fabrication techniques. However, separation of smaller micron-sized particles/bioparticles using 
inertial microfluidics presents a number of technical challenges [41], [48]. As shown in Equation 
1, the net lift force will decrease significantly with relatively small changes in particle size due to 
the fourth-order dependence. Therefore, additional developmental efforts are still needed for 
small micro and sub-micro particle separation using inertial focusing. 
As opposed to passive approaches, active methods apply various external fields on the 
particles/bioparticles; these include dielectrophoretic, magnetic, optical and acoustic fields [25]. 
In the following section, we briefly introduce electrophoresis, which applies a dielectrophoretic 
field on particles, as a typical example of the active methods.  
Electrophoresis is widely used as an active approach for particle discrimination and 
fractionation. When a particle is placed in a nonuniform electrical field, it becomes polarized and 
experiences a lateral force [49]. Electrophoresis enables electrically-controllable trapping, 
focusing, translation, fractionation and characterization of particulate mineral, chemical, and 
biological analytes within a fluid suspending medium [49]. Electrophoresis based separation is 
on the basis of their dielectric properties. It is feasible to separate mixtures of very small 
particles, such as mixed nanoparticle solutions into subpopulations. For example, a solution of 93 
nm diameter latex beads with a distribution of surface charge can be separated by 
dielectrophoresis [50]. Because the dielectric properties of a particle depend on both its structure 
and composition, dielectrophoretic forces access a much richer set of particle properties [49]. 
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However, the application of this approach is limited to separation of particles with significantly 
different electrophoretic responses [25]. High voltage required for device operation and very low 
throughput (0.009 µL/min [40]) are additional disadvantages.  
In general, the passive sorting methods are better than active approaches due to the 
absence of need for applied external forces, while the active techniques usually have better 
separation efficiency. Thus, passive sorting methods can be used where energy input is of critical 
concern, while active separation techniques are preferred where better concentration efficiency is 
desired.  
1.3.2 Antibody/antigen and alternatives Based Microbial Detection 
Antibody-based microfluidic detection is one of the main analytical techniques for 
microorganism detection. This powerful analytical tool employs immunological principles that 
rely on the intrinsic affinities between antigen and antibody to obtain the specific affinity. The 
majority of the systems for microorganism detection immobilize the antibody on a platform 
surface to detect the presence of antigens in samples [51], [52]. Antibody based microorganism 
detection in microfluidic systems has been demonstrated using different biosensing tools, 
including colorimetric detection [53], fluorescence [54], chemiluminescence [52], surface 
plasmon resonance [55] and impedance [56]. Following a different strategy, a diagnostic method 
was recently reported for detecting circulating antibodies using a specific antigen [57], which 
avoids the device selectivity being limited to the specificity of the antibodies used. Applying the 
antibody/antigen detection approach, infection by microorganisms such as influenza [58], E. coli 
[59], hepatitis B [52], HIV [60] and Zika virus [57] have been detected.  
Although antibody/antigen based detection systems are widely used, they suffer from 
some disadvantages, for instance, the use of animals for production of antibodies, poor stability 
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and high cost. There are several reported alternatives to antibody/antigen, for example, 
recombinant antibody-fragments (rAbs) [61], molecularly imprinted polymers [62], aptamers 
[63] and antimicrobial peptides [54]. We will succinctly cover these alternatives in the following 
section.     
Recombinant antibody-fragments (rABs), such as single chain variable fragments, are 
antibody fragments generated using recombinant antibody coding genes both as a source and as a 
display technology [64]. Unlike monoclonal antibodies, rABs do not require hybridomas and 
animals in the production process and only require synthetic genes [64]. As a result, rABs have 
comparable specificity to mAbs but much lower cost in production. For more details, interested 
readers can refer to an excellent review on antibody fragments as probes in biosensors [65]. 
Molecularly imprinted polymers (MIPs) are highly selective polymeric materials 
produced by the molecular imprinted polymerization, which leaves cavities in polymer matrix 
with affinity to a chosen “template” molecule [66]. MIPs can be produced at a low cost with high 
stability and high reproducibility. A detailed review on MIPs based biosensors can be found 
elsewhere [67]. As an alternative to antibodies, MIP-based pathogen detection preserves the 
original states and orientations of proteins to provide a high specificity and sensitivity [19]. For 
example, Heat shock protein 60 (Hsp60), which is a specific receptor for Listeria monocytogenes 
infection, has been used as capture probe for L. monocytogenes in a microfluidic format. By 
using Hsp60, the binding efficiency and sensitivity were much greater than those observed using 
a monoclonal antibody [68].  
Aptamers are short nucleic acid or peptide molecules produced by in vitro processes and 
are capable of binding specific target molecules with enhanced affinity and specificity [69]. 
However, attempts to use aptamers in practice have been shown to be less efficient than initial 
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expectations, partly due to the lengthy selection time [66]. A detailed review to address the 
problems, solutions and prospects of aptamer based diagnostics and therapies is available 
elsewhere [69].   
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs), are part of the 
innate immune response found among all forms of life [70]. When compared to antibodies, 
AMPs are advantageous with better stability, long-term functionality, and broad-spectrum 
detection. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram 
positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells [70]. If the 
goal is to detect a broad range of pathogens, AMPs are very useful due to semi-selectivity toward 
the targets. However, for the detection of a specific pathogen, antibody based detection is better 
than AMPs. 
1.3.3 DNA/RNA Nucleic Acid Based Microbial Detection 
The fundamental methods developed for nucleic acid based detection are nucleic acid 
hybridization, polymerase chain reaction (PCR), and fluorescence based techniques [71], [72]. 
Among these detection technologies, hybridization based methods have been shown to be 
superior because they are highly sequence-specific, direct, rapid and economical for detection of 
infectious diseases.  
In the hybridization strategy, a specific sequence of DNA is utilized as the probe to 
capture complimentary target DNA or RNA. Unlike antibodies, nucleic acid used as the probe of 
a sensor can be easily and readily synthesized. The accumulated knowledge of peptide nucleic 
acid (PNA) has opened a new research area of DNA biosensors. PNA is a DNA analogue with a 
peptide backbone instead of a sugar phosphate backbone [19]. Compared to DNA or RNA, 
PNAs hold the advantages of better chemical and thermal stability, resistance to enzymatic 
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degradation, faster hybridization kinetics, and the ability to hybridize at lower salt 
concentrations. One drawback of the PNA probes are their relatively high cost compared to DNA 
probes.  
In the hybridization approach, the biological event of DNA/RNA hybridization is 
converted into measurable and recordable signals in direct proportion to the concentration of 
analytes [73]. Microsystem DNA/RNA-based detection systems have been coupled to different 
measurement techniques to detect hybridization events, including amperometric (current 
measurement at constant potential) [74],  potentiometric (potential measurement at constant 
current) [75], impedance (measurement of changes in resistance) [76], piezoelectric 
(measurement of changes in mass) [77], thermal (measurement of changes in temperature) [78] 
or optical (detect changes in transmission of light) [71].  
Due to minimal direct detection levels varying between 105-106 target molecules without 
any signal amplification technologies, target probing using hybridization-based assays are 
limited in terms of sensitivity, thus requires additional signal enhancement techniques. Many 
techniques have been applied to improve the sensitivity, including optical, fluorescent, and 
electrochemical methods[79]. The first two approaches enhance both the specific and nonspecific 
signals, thereby leading to increases in potential false positives and deterioration in selectivity. In 
contrast, the electrochemical method directly detects targets and no further chemical 
modification is needed on the probes. This method is preferred also because the electrochemical 
signal can be generated and measured only at events involving specific binding, which 
circumvents the specificity issue, especially in complex matrices such as blood or serum [80].  
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1.4 Objectives of this dissertation 
The general goal of this dissertation is to develop point-of-care platforms that capture the 
key elements of gold standard methods for whole microorganism separation, nucleic acid and 
antibody detection in low-resource settings. To build such platforms, several issues will need to 
be addressed, which are discussed below.  
To achieve the goal of the whole microorganism concentration for point-of-care 
applications, passive microfluidic separation approaches are better than the active microfluidics 
because the passive methods do not require additional reagents, external fields or electronics, 
making them suitable for low-source settings. Among all the microfluidic bioparticle passive 
sorting techniques introduced above, inertial focusing microfluidics is superior to the other 
approaches due to its capability for very high throughput, high separation efficiency and simple 
fabrication requirements. Over the past ten years, there have been a number of studies 
demonstrating the effectiveness of inertial focusing in a microfluidic format to isolate and 
concentrate mammalian cell-sized particles and bioparticles, but much less work has been done 
on micron and submicorn-sized particles. Thus, the first aim of this dissertation (Chapters 2 and 
3) is to develop a powerful platform to sort these smaller particles using inertial focusing 
microfluidics, and validate this platform with a microorganism based on its separation 
performances and throughput per footprint.   
One fundamental limitation to direct and practical point-of-care pathogen detection 
(nucleic acid or antibody) is posed by the trace quantities of microbes typically present in 
samples, even though such low concentrations may have the potential to be lethal. Since most of 
the detection levels of developed DNA or antibody sensors vary between 105-106 target 
molecules, direct target capture assays are limited in terms of sensitivity [79]. Therefore, the aim 
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of this part of dissertation (Chapters 4 and 5) is to develop ultrasensitive platforms for trace 
pathogen nucleic acid and anti-pathogen antibody detection without the need for sample 
enrichment or signal amplification. The development of such diagnostic platforms in general will 
greatly benefit public health agencies worldwide to monitor emerging infectious diseases of 
global importance in future.  
1.5 Organization of the Dissertation 
In this section, brief outlines of each chapter are given.  
Chapter 2. “High-Throughput Inertial Focusing of Micrometer- and Sub-Micrometer-
Sized Particles Separation”. In this chapter, a serpentine channel inertial focusing microfluidic 
system has been designed, fabricated and validated. This part of study demonstrated that inertial 
migration and Dean flow can be effectively and efficiently applied as a powerful tool for inertial 
focusing of micron-sized particles and bioparticles with high throughput. The unique chips 
designed for 2 µm and 0.92 µm particles have been constructed using a rigid and easy-to-process 
polymer. A wide range of flow rates has been tested for this design to achieve as high-throughput 
as possible. The minimum length of the serpentine channel has been explored to reduce the 
footprint and it was found to be significantly shorter in length than those in other published 
studies. For the applications to biological samples, the focusing performance of the chip has been 
investigated for deformable bioparticles, specifically cyanobacteria.  
Chapter 3. “A microfluidic concentrator for cyanobacteria harvesting”. As an example 
of microorganism separation, the inertial focusing microfluidics studied in Chapter 2 has been 
adapted specially to concentrate Cyanobacterium Synechocystis sp. PCC 6803 with a typical size 
of 2 µm. The operating parameters for inertial focusing of the cyanobacteria suspension have 
been optimized to achieve high-throughput and high-efficiency concentration. Once focused, the 
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stream of cyanobacteria can be readily separated from the culture medium to obtain a 
concentrated product. The recovery efficiency and concentration factor are used to evaluate the 
performance of this inertial focusing platform for micro-algal applications.  
Chapter 4. “A sensitive DNA capacitive biosensor using interdigitated electrodes”. This 
chapter presents a label-free affinity-based capacitive biosensor to detect trace viral DNA using 
interdigitated electrodes. The gold interdigitated electrode surface was functionalized with DNA 
probes based on the West Nile virus sequence (Kunjin strain). The protocol of DNA probe 
preparation has been optimized in order to minimize the effect of contaminants in commercial 
thiolated DNA probes. The DNA binding results presented in this chapter were validated using 
fluorescent oligomers. The reproducibility of the biosensor detection was improved with 
modification of single-stranded DNA probe oligomers and gold microelectrodes. The detection 
limit and the dynamic range of the detection have been examined to verify that it is suitable as a 
practical point-of-care (POC) platform for ultrasensitive clinical applications without the need 
for amplification.  
Chapter 5. “An Ultra-Sensitive Capacitive Microwire Sensor for Pathogen-Specific 
Serum Antibody Responses”. This chapter is dedicated to the construction and testing of an 
ultrasensitive biosensor for label-free, rapid detection of ultra-low concentrations of virus-
specific antibodies. A simple and robust capacitive biosensor based on Zika or Chikungunya 
antigen-coated microwires has been developed, optimized and validated with monoclonal 
antibodies and polyclonal antibodies in mouse serum. The specificity and detection limit have 
been evaluated. In addition, the anti-ZIKV antibodies during an immunization time-course 
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CHAPTER 2: HIGH-THROUGHPUT INERTIAL FOCUSING OF MICRON- AND 




The ability to continuously and reliably concentrate and separate small diameter 
bioparticle ( pD ≤ 2 µm) suspensions, such as bacteria, subcellular organelles and even virus that 
are flowing through microchannels, offers significant potential for biomedical,[1] 
environmental,[2,3] food analysis,[4] and biofuel production[5] applications. Typically, 
bioparticle concentration and separation are accomplished through industrial or laboratory 
centrifugation, where there is a correlation between the size and density of the particles and the 
rate that they separates from a heterogeneous mixture.[6] When the particle size is very small 
and its density is comparable to the mixture medium, as with bacteria, virus and subcellular 
organelles, a high speed or even ultra-high speed centrifuge operating for a long periods of time 
is required.[6] For moderate volumes of small bioparticle suspensions, centrifugation will work 
but may result in mechanical damage to the cells due to high shear forces.[7,8] In typical clinical 
samples where the bacteria/virus numbers are often low and the sample volume is small, 
centrifugation may be inadequate at concentrating or separating the suspension 
constituents.[9,10] On the other hand, in industry applications such as cyanobacteria harvesting 
for biofuel production, large-scale concentration of a dilute cell suspension entails significant 
power requirements associated with high speed centrifugation.[11]  
                                                          
1 This chapter is published in the following: Wang L, Dandy D.S., (2017) High-throughput 




Consequently, a simple but robust platform able to provide significant improvements over 
current concentration techniques is needed. Ideally, a concentration/separation device for small 
diameter particle/bioparticle suspensions would be as simple as possible in its design, not require 
additional reagents or external electronics, and be inexpensive to fabricate and operate. Also, the 
device should be readily scalable so that the basic technology could be applied to sample 
volumes ranging from milliliters to hundreds of liters. And the device needs to be sufficiently 
small to potentially integrate with other point-of-care platforms. 
The use of microfluidics has streamlined many traditional laboratory techniques, due to 
the advantages of ease to operation, low-cost, and miniaturized size.[12]  In the specific 
application to particle/bioparticle concentration and separation, inertial focusing is a very 
promising approach that relies solely on channel geometry and intrinsic hydrodynamic 
forces.[13–18]  The application of inertial focusing devices has been used for precise 
manipulation of erythrocyte-sized cell suspensions for a number of applications in clinical 
diagnostics.[14,19–21] However, separation of smaller, micron-sized bioparticles is challenging 
using current inertial microfluidics approaches.[16,21–23]  
To address the challenge, a better understanding on the mechanism of inertial focusing is 
necessary to find potential solutions. The inertial focusing phenomenon arises from lateral forces 
exerted on particles in a dilute suspension as they are transported in flow with a non-uniform 
velocity profile under laminar conditions. The equilibrium migration location of particles 
depends on a number of factors, including the ratio of the particle size to the channel dimensions 
and the Reynolds number, Re,[16,20] which is a dimensionless parameter quantifying the ratio of 
inertial forces to viscous forces.[14] In laminar channel or tube flow, each particle experiences a 
force associated with the parabolic velocity profile. This force, the shear gradient lift force ( ), 
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pushes particles away from channel centerline. At the same time, the channel wall exerts a wall-
effect lift force ( ) that pushes the particles away from the channel or tube wall[16]. The net 
lift force ( ) in a rectangular channel can be expressed as[16] 
  (1) 
where  is the fluid density,  is the maximum channel velocity, is the particle diameter,  
is the lift coefficient, and  is the hydraulic diameter, where and are the 
height and width of the channel cross-section, respectively. As shown in equation (1), the net lift 
force will decrease significantly with relatively small changes in particle size due to the fourth-
order dependence. To overcome this effect and obtain a focused particle stream, smaller cross-
sections and larger velocities are needed. In this study, a channel with appropriately scaled 
dimensions for small particle/bioparticles suspensions has been designed and fabricated.  
The working flow rates in current inertial focusing microfluidics platforms are usually at 
modest Reynolds numbers (Re ≈ 100),[16,22,24] which  limits the ability to focus small particles 
at high throughput in a single microchannel. However, when higher velocities are required, the 
low elastic modulus of the widely used material Polydimethylsiloxane (PDMS) makes its use 
problematic for this microfluidics application, resulting in cross section deformation and a loss of 
focusing at higher flow rates.[21,23] Other polymers with comparably simple fabrication 
procedures—but much higher rigidity—are needed. A benefit of using higher flow rates is the 
potential for reduction in channel length, from several centimeters[16] down to millimeters.  The 
reduced size should also lead to reduced pressure drops and pumping requirements.[16] 
To get a better separation outcome, fewer particle equilibrium positions are favorable.  In 
a tube of circular cross section, randomly distributed particles are known to focus to an annulus 
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located six-tenths of the distance from the axis to the tube wall,[13] whereas in a channel of a 
square cross-section the particles focus to four equilibrium regions centered near each face.[16] 
The number of focused particle streams can be reduced by introducing curvature to the flow 
path.[14] The inertia of the fluid moving through a channel bend creates secondary swirling 
motion, known as Dean flow.[14,15] The resulting hydrodynamic drag enhances the lateral 
migration of particles across the channel. There are two major classes of curved channels: a 
spiral geometry[18,25,26] and a serpentine channel geometry with asymmetric[14,15,27] or 
symmetric configurations.[28,29] In this design, an serpentine channel is used to reduce the 
number of focused particle streams.  An added benefit of this slightly increased geometric 
complexity is a reduced flow length required to achieve focusing relative to straight 
channels.[16,30]  The linear layout of the asymmetric curved channel has one more advantage—
its ability to be parallelized, which allows for increased throughput. 
In sum, a simple, robust device for inertial focusing of micron- and submicron-sized 
particles and bioparticles for concentration and separation at high throughput has been designed, 
constructed, and validated. There are a broad set of potential applications for this platform, such 
as pathogen and subcellular organelle isolation, separation of virus from bacteria, microalgae 
harvesting, and monitoring heterogeneous response of bacteria in drug susceptibility testing.  
2.2 Experimental Section 
2.2.1 Microfluidic Device Fabrication  
For TPE chip fabrication, we first created a SU-8 2008 mold (Microchem, MA, USA) 
using conventional photolithography.[31] The SU-8 patterned silicon master was treated by 
vapor deposition with hexamethyldisilazane (HMDS) (Sigma-Aldrich, MO, USA) in a 60°C 
oven for 4 h prior to replica molding with TPE. TPE was prepared by mixing 20 g resin (TAP 
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Clear-Lite Casting Resin, CA, USA) with 0.2 g MEPK catalyst (TAP plastics, CA, USA), and 
then the mix was stirred and degassed to remove air bubbles. A piece of PDMS was cut to form a 
mold surround, which confined the mix in a specific area on the master. Then the TPE mix was 
poured onto the mold. A piece of transparency film was used as a top cover over the mix to 
ensure a flat surface. The TPE is placed in a 65°C oven for 10 minutes, after which the TPE 
replica is peeled from the master. A biopsy punch (Technical Innovations) was used to create 1.5 
mm diameter inlet and outlet ports. The TPE replica and a glass substrate were then placed in a 
plasma chamber and pumped down to 200 mTorr, and the pieces exposed to plasma (Plasma 
Etch, Carson City, NV, USA) for 1 min, at pressures between 100 and 200 mTorr, and 30 W 
applied to the RF coil. After removal from the plasma chamber the TPE piece is brought into 
contact with the glass. The TPE-glass chip is then left to cure in a 60°C oven for 5 min. To 
enable pressure-driven flow through the TPE-glass hybrid devices, tubing connectors (Nanoport, 
WA, USA) are attached to the chip using room temperature cured epoxy.  
2.2.2 Experimental Setup and Method  
During each experiment, the 2 µm red or 0.92 µm green fluorescent polystyrene 
microsphere suspensions (Thermo Scientific, MA USA) with specific concentrations (0.01, 0.1, 
and 1 v/v%) in DI water were pumped into the microfluidic device at varying flow rates using a 
high pressure injection syringe pump (Harvard Apparatus, MA, USA) to generate a stable and 
continuous flow. The inlet of the device was connected to a syringe by Tygon tubing. For the cell 
experiments, known concentrations (0.01 v/v% ~ 2.5×106 mL–1; 0.1 v/v% ~ 2.5×107 mL–1; and 1 
v/v% ~ 2.5×108 mL–1) of cyanobacteria culture in the syringe were pumped into the device in the 
same manner as fluorescent microspheres. The suspending medium for the cyanobacteria in the 
inertial focusing experiments is a liquid BG-11 medium. 
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2.2.3 Cyanobacteria Source and Cultivation  
Cyanobacterium Synechocystis sp. PCC 6803 was grown in liquid BG-11 medium.[32] 
The strain was inoculated at an initial concentration of 106 mL–1 and cultured in 250 mL 
Erlenmeyer flask with 50 mL culture medium in an INNOVA 44 Incubator Shaker (New 
Brunswick Scientific, Enfield, CT) at a speed of 225 rpm under 30°C at an average light 
intensity of 100±9 µmol/m2·s. These 50 mL suspensions were cultured to a final concentration 
between 2×108 and 5×108 mL–1. The suspension was then diluted or concentrated to achieve the 
desired density for the inertial focusing studies.  
2.2.4 Fluorescence Imaging  
TPE-glass devices were mounted onto the stage of an inverted fluorescent microscope 
(AMG, Mill Creek, Washington). Fluorescent streak images were obtained using a GFP light 
cube (excitation/emission: 470/510 nm) with exposure times of 200 ms. Recorded images were 
processed using ImageJ (http://rsb.info. nih.gov/ij/). 
2.2.5 High-speed Imaging  
The flow of the cyanoabcteria suspension was recorded at 2000 frames per second (495 
μs interval) with a 5 μs shutter speed using a high-speed camera (Fastcam SA3, Photron, USA) 
connected to an Olympus IX 71 Inverted optical Microscope (Olympus, Japan). 
2.2.6 Image Analysis and Measurement  
Image analysis was conducted using ImageJ (http://rsb.info.nih.gov/ij/). The 
concentrations of cyanobacteria were measured by a hemocytometer (hausser Scientific 
Partnership, Horsham, PA), and the suspension concentrations were then calculated from three 
different hemocytometry measurements. 
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2.3 Results and Discussion 
2.3.1 Design of the Focusing Device.  
The experiments done here have successfully demonstrated inertial focusing of 2 µm red 
and 920 nm green fluorescent polystyrene spheres using an asymmetric serpentine channel. 
Figure  2.1a, at the center of Figure 1, shows the top-view a schematic of the entire microfluidic 
device, for which there are five functional components: (1) an inlet to introduce the 
homogeneous suspension; (2) a filter region to prevent channel clogging by trapping larger 
particles; (3) a 33.3 mm-long asymmetric serpentine channel to focus the particles (doubling 
back to reduce the device length); (4) a separation region to isolate particle streams from media; 
and (5) three collection outlets. The serpentine microchannel geometry was selected because it 
enhances the rate of lateral particle migration. That is, at a sufficiently large value of the Dean 
number (De), at which point the Dean drag the same order of magnitude as the lift force,  curved 
channels result in faster focusing to predicted equilibrium positions than straight channels for the 
same Reynolds number[16,30]. It is noted that the lift force is the dominant focusing mechanism 
moving particles to their equilibrium positions; the additional force from Dean flow does not 
focus particles, but it serves to reduce the number of equilibrium positions from four to one and 
to speed up the focusing process. Due to the small size of the particles, a correspondingly small 
channel cross section is needed to enable and maintain inertial focusing.  
In studies with 2 µm particles and bioparticles, the microchannel height is a uniform 10 
µm and the serpentine channels have a width of 20 µm on the small curvature bends, both of 
which are critical parameters that determine focusing performance. One small and one large turn 
is defined as a unit, such that the length of 3 units is 1 mm. The separation channels are designed 
to range from 12 units (4 mm) to 100 units (33.3 mm).  Figures. 2.1b’, c’ and d’ show the 
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progression of inertial focusing processes for 2 µm red fluorescent polystyrene spheres in a 12-
unit configuration. The particle suspension is introduced into the inlet by a syringe pump, and the 
suspension enters the serpentine channel region after passing through the filter. At the beginning 
of the suspension section (Figure. 2.1b’), the band of red fluorescent particles spans the width of 
the microchannel. However, as the suspension passes through the units, the width of the particle 
stream continuously narrows to the point where the particles are focused (Figure. 2.1c’). After 
the focused stream leaves the serpentine section it is isolated from the particle-free liquid in the 
separation region. 
 
Figure 2.1 Images showing the design and use of a serpentine microfluidic network for focusing for 2µm 
red fluorescent spheres. (a) A schematic top view of the entire inertial focusing platform. The total length 
of the serpentine curved microchannel section is 4.5 cm in this design. (b) Enlarged image of the 
serpentine curved channel. (b’) Fluorescence image of the 2µm red fluorescence particles streams in 
locations corresponding to (b). (c) Magnified image of one serpentine unit, in which the channel width of 
the small bend is 20 µm and the width of the large bend is 80 µm. (c’) Fluorescence images of the focused 
2µm red fluorescence particle stream at a location corresponding to Figure (c). (d) Magnified image of the 
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isolation region. (d’) Fluorescence images of the focused 2µm red fluorescence particle stream in the 
isolation region. The white dashes represent the boundaries of microchannels. 
 
As discussed above, the small size of the particles requires a higher flow rate (Re) relative 
to larger particles, to obtain a sufficiently large lift force. And because of the linear relationship 
between flow rate and pressure drop per unit length in Poiseuille flow, significant pressure is 
applied to the liquid. Under these circumstances, despite its fabrication simplicity and 
widespread use, PDMS is a not an appropriate choice for the microchannel material; pressure-
induced deformation of the channel cross section results in a total loss of the focusing 
effect.[21,23] Thermoset polyester (TPE) was identified as an alternative polymeric material with 
similar fabrication procedures to PDMS as well as optical transparency, but with much higher 
rigidity.[21] Young’s modulus for TPE is approximately 1.2 GPa, or 1,000×  higher than 1:10 
PDMS.[21] The inertial focusing microfluidic chip was fabricated in TPE by single-layer soft 
photolithography with several processing changes from reported methods [33–37] to obtain 
needed versatility for a wider range of applications. First, a 3 min UV light curing step[33,35,37] 
was replaced with a 10 min 65°C thermal cure. This modification eliminates the need for photo 
initiator in the resin mix for UV curing, and results in improved optical transparency of the TPE 
layer and also reduces the cost for chip fabrication. Second, although fully cured TPE is a rigid 
polymer, it was still possible to use standard PDMS punches to create inlet and outlet ports by 
doing a partial thermal cure, punching the inlets and outlets, and then completing the cure with 
room temperature O2 plasma treatment for sealing. The detailed procedure is illustrated in 




Figure 2.2 Schematics illustrating the procedure to fabricate the thermoset polyester (TPE) inertial 
focusing microfluidic system.  
 
2.3.2 Effect of Particle Size.  
Within the curved channel region, the theory associated with the superposition of the 
lateral lift forces and secondary flow is complicated, but there is a dimensionless parameter, the 
inertial force ratio,[16] that quantifies the magnitude of this effect: 
                                                                                          (2) 
This parameter contains the particle size , the largest radius of curvature, , and the 
smallest channel dimension, which is  in this device. When > 0.04, the coupling of lift force 
and Dean flow will guide particles to a stable equilibrium position.[16] By design, for the 2 µm 
particles in the network shown in Figure. 2.1 the ratio is  = 0.6, which is well above the 
necessary threshold. Figure. 2.3b shows results for focusing experiments with a 0.01 v/v% 
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suspension of the 2 µm spheres at a flow rate of 500 µL/min (Re = 554). The streak width, that 
is, the full width at half maximum (FWHM) of the intensity profile is 2.12 µm at this flow rate. 
When the measured FWHM is less than twice the particle diameter, the particle stream is defined 
as focused.[16] There is a common view that it is difficult to precisely focus microparticles in 
asymmetric serpentine channels [38] because the steak widths are often two to three times the 
particle diameter in size.[27,39] However, the results from this study show that the streak width 
is essentially the same as the particle diameter at low particle concentrations, strongly indicating 
that the suspension flows single file along a pathline. The ability to truly focus particles in a 
curved channel network depends strongly on two quantities, the flow rate and channel cross 
section dimensions. As indicated above, the Reynolds number in this experiment significantly 
exceeds 100, which is a typical value reported in other inertial focusing studies.[27,39] This 
operating condition is clearly important since the magnitude of the lift force scales as the square 
of the maximum fluid velocity, as shown in equation (1). At the same time, the magnitude of the 
secondary flow velocity, DU , also varies as the square of that maximum velocity as  
                                                                                       (3) 
where  is the Dean number, and µ and ρ are the liquid dynamic viscosity and 
density, respectively.[18]  For these studies the cross-section dimensions and particle size are 
fixed, so flow rate plays a major role in the focusing process. The reason that the focusing effect 
is lost under these conditions when using PDMS is also evident in equation (1); the higher 




Figure 2.3 The effect of particle size on focusing efficiency. (a) The channel cross-section of 20 µm × 
10 µm is designed for 2 µm particle focusing. (b) Fluorescence image of 2 µm red fluorescent particles in 
the final curve of the serpentine microchannel. A single equilibrium focusing location is seen in the 
straight channel region. (c) The corresponding fluorescence intensity profile across the width (w) of the 
straight channel region. (d) The channel cross-section of 10 µm × 5 µm is designed for 0.92 µm particle 
focusing. (e) Fluorescence image of 0.92 µm green fluorescent particles in the final curve of the same 
serpentine microchannel. (f) The corresponding fluorescence intensity profile across the width (w) of the 
straight channel region. The FWHM is calculated from a fitted Gaussian curve. The white dashed lines 
represent the microchannel boundaries. 
 
A suspension of smaller 0.92 µm spheres was also flowed through this serpentine 
network at the same flow rate and concentration as the 2 µm spheres. As shown in 
supplementary Figure. 2.4, the FWHM streak width is 4.10 µm, which is 4.5 times the 0.92 µm 
sphere diameter. This relatively reduced focusing effect is simply due to the smaller particle size 
and resulting net lift force. However, despite the fact that these particles are, technically, not 
focused, the lift ratio is  = 0.13 and the relative narrowness of the streak width is significant 
because the magnitude of the lift force on the 0.92 µm spheres is less than 5% of that 
experienced by 2 µm spheres. The inertial migration effect isn’t sufficiently large enough to 
more tightly group the smaller particles, but it nevertheless displaces them with surprising 
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efficiency. These results indicate that further tuning of channel dimensions offers the possibility 
of focusing submicron particles. In follow on studies, a microchannel with reduced cross-section 
( = 10 µm and = 5 µm) was designed and tested with the 0.92 µm green fluorescent 
microspheres at the same flow rate. There, the FWHM is 1.07 µm, as shown in Figure. 2.3 f. 
This result demonstrates that submicron-sized particles can also be focused using inertial forces. 
One disadvantage of this separation technique is that the fixed channel dimensions constrain 
operation to a relatively narrow range of particle sizes. However, it is possible to design a serial 
microchannel network configuration with different channel cross-section dimensions in each 
stage or segment, whereby particles are focused and removed in order of decreasing particle size. 
For similar-sized particles (e.g., 2 µm and 3 µm), a single channel could be used to produce a 
separation of the two sizes. Both sizes would be focused, but on distinguishable pathlines, and 
the outlet microchannel configuration designed based on knowledge of the different equilibrium 
positions.  
 
Figure 2.4 Fluorescence image of 0.92 µm-sized green fluorescent particles in the final curve of the 
serpentine microchannel. The corresponding fluorescence intensity profile across the width of the straight 
channel region (w = 20 µm, h = 10 µm). The FWHM is calculated from a fitted Gaussian curve. The 




2.3.3 Effect of Channel Length.  
The channel length is ultimately a critical factor in fabrication cost and power 
consumption, as well as the ability to scale up to process larger volumes, e.g., in the mL/s range. 
A logical issue to address, then, is the minimum length of the serpentine section required to focus 
the micron-sized particles. Typical channel lengths reported in the literature are on the order of 
several centimeters.[14,17,38,39] In this study, 100 units of the serpentine channel (33.3 mm 
total length) were chosen for focusing the 2 µm spherical particles in large part because of much 
lower flow rates that were initially investigated.  
 
Figure 2.5 The dependence of focusing efficiency on serpentine focusing region length. (a) – (f) 
Fluorescence images of 2 µm red fluorescent particles in the final curve of serpentine microchannel for 
channel lengths ranging from 4mm to 9mm. (g) The fluorescence intensity profiles across the width of the 




As shown in Figure. 2.5, this length did result in very good focusing characteristics. 
Subsequently, serpentine channel lengths ranging from 4 mm to 9 mm have been designed and 
tested. The flow rate is fixed at 700 µL/min (Re = 776) in all runs, and the 2 µm fluorescent 
spheres introduced at a concentration of 0.01 v/v%. The fluorescence images and scanned 
profiles are shown in Figure. 2.5 For all of the different channels lengths the microspheres are 
tightly focused into a single particle stream and the lateral position of each particle stream is the 
same regardless of focusing region length. The minimum serpentine channel length considered 
here, 4 mm, is almost one tenth that of the most reported inertial focusing channel 
lengths.[14,17,22,38]  
To investigate the minimum length of serpentine channel required to focus 2 µm 
particles, additional serpentine channels, ranging in length from 1 mm to 4 mm, were designed 
and tested with a 0.01 v/v% suspension concentration. The resulting fluorescence images for 
these different microchannel lengths are shown in Supplementary Figure. 2.6 for a range of flow 
rates. The degree of focusing as a function of flow rate and channel length follows an interesting 
pattern. In the longest channel (4 mm), the 2 µm particles are focused at all flow rates 100 
µL/min and higher, whereas in the 3 mm microchannel the particles are only focused at 
intermediate flow rates; and in the 2 mm microchannel focusing only occurs at a single flow rate. 
In the shortest channel, focusing isn’t observed at any flow rate. Together, these results indicate 
that a minimum channel length (6 serpentine units, or 2 mm) and a minimum flow rate (100 
µL/min) are both required to successfully focus 2 µm particles. An important advantage gained 
by obtaining a shorter focusing distance is decreased hydraulic resistance, and therefore, 




Figure 2.6 The minimum serpentine microchannel length required for inertial focusing of micron-sized 
particles. Fluorescence images of 2 µm red fluorescent particles in the final curve of the serpentine 
microchannel for serpentine channel lengths ranging from 1 mm to 4 mm and flow rates ranging from 50 
µL/min (Re = 55.4) to 400 µL/min (Re = 443). The white dashed lines represent the microchannel 
boundaries. 
 
2.3.4 Effect of Flow Rate.  
Just as reducing channel length increases throughput-per-footprint, so does an increase in 
the maximum practical flow rate. To further explore the effect of this parameter on device 
operation, a range of flow rates, from 10 µL/min (Re = 11.1) to 1,400 µL/min (Re = 1,550) were 
investigated. Figure. 2.7 shows fluorescence images in the straight channel section immediately 
downstream of the serpentine region, as well as the intensity scan across the channel width. It 
may be seen that, for this 0.01 v/v% concentration, the degree of focusing continuously improves 
as flow rate is increased from 10 µL/min (Re = 11.1) to 100 µL/min (Re = 111). As the flow rate 
is increased beyond this value, however, there is no noticeable effect on focusing because the 
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particles already lie on a single pathline. This result is in contrast to observations made in 
straight focusing channels at similar values of Re.[23] Specifically, in another study using 
straight focusing channels, the number of focused streams varied from one to three as flow rate 
increased.[23] This difference is consistent with the observation that Dean flow in serpentine 
channels efficiently aligns the particles into equilibrium positions that remain stable in the 
downstream straight channel section, and enables focusing to a smaller subset of equilibrium 
positions that are stable in the presence of the superposed secondary flow. As for the correlation 
between the strength of the secondary flow and the particle distribution, there is no 
straightforward relationship because a number of parameters (e.g., microchannel dimensions, 
particle size, channel radii of curvature, and Reynolds number) are involved, as indicated in the 
expressions above for the inertial force ratio and Dean number.  In this design, the only 
adjustable parameter is Reynolds number. Therefore, the magnitude of secondary flow and 
Reynolds number are proportionally related by a constant. One thing that does vary with the 
Reynolds number or secondary flow in the current system is the lateral equilibrium position of 
the focused stream. Although the effect is small, the particle stream moves closer to the channel 
sidewall as Reynolds number or secondary flow strength is increased. Note that the apparent 
width of the particle streams is larger at higher flow rates. This effect is an artefact of the 
visualization technique that results in an increased number of particles passing through detection 




Figure 2.7 Flow rate dependence of inertial focusing efficiency for micron-sized particles. The left 
two images show the observation direction and observation region for the images on the right. The 
intensity images and scans show the fluorescence intensity from 2 µm particles under the flow rates 
ranging from 10 µL/min (Re = 11.1) to 1400 µm/min (Re = 1550). The horizontal blue dashed line in each 
scan demonstrates the shift in particle streak location toward the sidewall as flow rate is increased. The 
white dashes represent the microchannel boundaries. 
 
2.3.5 Effect of Suspension Concentration.  
Another important feature of a high throughput device is the ability to focus and separate 
a wide range of suspension concentrations, while at the same time, recognizing that this 
phenomenon is concentration dependent.[16,27,38]. Specifically, focusing suspensions with high 
concentrations can be problematic due to particle-particle interactions that work against the 
lateral lift force mechanism. As shown in Figure. 2.8a, the width of focused 2 µm particle 
streams increases as particle concentration increases from 0.01 v/v% (FWHM = 2.07 ± 0.03 µm) 
to 1 v/v% (5.98 ± 0.03 µm). For these experiments, the flow rate was held constant at 1000 
µL/min and the serpentine channel length was 4 mm. The images and plots in Figure. 2.8 
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illustrate several phenomena. First, the FWHM of the particles streams are much less than twice 
the particle diameter when the particle concentrations are low (0.01 and 0.1 v/v%), which 
conclusively demonstrates focusing,[24] as shown in the lower left (pink) region of Figure. 2.8b. 
Second, the locations of the particle streams do not change appreciably as particle concentration 
increases.  Third, it is found that, at 1 v/v%, the FWHM of the stream is 5.98 µm, which is almost 
three times the particle diameter. Based on the standard definition applied at the lower 
concentrations,[24] this stream would be considered unfocused. However, simply due to 
geometric constraints there is a tendency for the particles to line up on adjacent pathlines and 
form “particle trains”.[40] To explain this higher concentration phenomenon, a length fraction  
is introduced, where this quantity is the number of particle diameters per channel length[16]. The 
length fraction ( ) can be related to the suspension volume fraction as  
                                                                    (4) 
where  is the suspension volume fraction, is the channel cross-sectional area,  is the 
channel width, and is the channel height.[16] In theory, when < 0.5, there can be a single train 
of aligned particles; the minimum number of particle trains increases from one to two when > 
0.5, which is shown in the middle region (green) in Figure. 2.8b, and then three trains when > 
1, represented by the rightmost (blue) region.[40]  For the suspension concentrations used here, 
the corresponding  values are 0.0095 (0.01 v/v%), 0.0955 (0.1 v/v%), and 0.9549 (1 v/v%), as 
shown in Figure. 2.8b. There needs to be a minimum of two particle trains when the suspension 
concentration is 1%, and the focusing criterion is thereby adjusted to be FWHM , where 
 is the minimum possible number of particle trains. In this study, then, the 1.0 v/v% 
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suspension is focused because the FWHM < 8 µm. The upper limit of length fraction considered 
in this study is 1 to avoid defocusing due to strong particle interactions and crowding.[38] 
 
Figure 2.8 The dependence of focusing efficiency on the initial suspension concentration for 2 µm 
particles. (a) The measured FWHM visibly increases as particle concentration is increased. (b) The lower 
left region (pink) denotes the range of 2µm particle concentrations that theoretically can be focused onto a 
single particle train (pathline). The data points in this region demonstrate that focusing is achieved. The 
region above this (white) represents unfocused operation. The adjacent region (green) corresponds to a 
range of particle concentrations (~0.52 to 1.05 v/v%) that cannot physically fall onto a single pathline, but 
may form two adjacent particle trains. Using this as a focusing criterion, the results for the 1 v/v% 
suspension indicate that focusing is achieved. The final region in the plot (blue) demotes focusing for 
concentrations above ~1.05 v/v%. The white dashes represent the microchannel boundaries. Error bars 
represent standard deviation with a sample size of three. 
 
As discussed above, this device is effective at focusing a dilute suspension (0.01 v/v%) of 
2 µm particles at high flow rates, up to 1400 µL/min, using short (4 mm) channel lengths. The 
ability of the device to focus and concentrate higher suspension densities—0.1 and 1.0 v/v%—
was also quantified. For the outlet configurations shown in Supplementary Figure. 2.9a, 
concentration performance (yield efficiency) was measured. As shown in Supplementary Figure. 
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2.9b, at 500 µL/min, the yield efficiencies for the higher concentrations (0.1 v/v% and 1 v/v%) 
rival the performance of the lowest concentration (0.01 v/v%). At 700 µL/min (Supplementary 
Figure. 2.9c), the yield percentage is similar to the 0.01% performance, that is, above 99%. Thus, 
a concentration factor of over 100 with high yield efficiency is feasible if the channels were 
configured as a cascade, with the product stream of one flowing to the inlet of another.  
 
Figure 2.9 The concentration profiles of the 2 µm particle suspensions for a range of inlet suspension 
densities. (a) The outlet design is based on the predicted locations of focused particle streams for 
separation into three zones. Z1 and Z3 are intended for the waste (particle-free) streams, and Z2 is 
designed for the concentrated product stream. (b) The yield percentage of 2 µm particles at a flow rate of 
500 µL/min. (c) the yield percentage of 2 µm particles in the 1 v/v% suspension at three different flow 
rates. Error bars represent the standard deviation with a sample size of three. 
 
A suspension concentration of 0.01 v/v% is equivalent to 107 mL–1, and this is 
approximately the highest concentration of cyanobacteria in a fully cultured state (e.g., in an 
open pond).[41] In other words, a 0.01 v/v% concentration covers most of the applications in 
industrial or laboratory settings, for example, bacteria sample pre-concentration for nucleic acid 
extraction, or bacteria separation in water or milk. For some specific industry applications, 
highly concentrated bacteria suspensions are needed to extract bio-products. Cyanobacteria-
based biofuel production is a good example for this. The suspension concentration after the 
culture process is not high enough in these applications for harvesting or dewatering to be 
economically feasible, and additional processes are needed to further increase the concentration. 
45 
 
The higher working concentrations of 0.1 v/v% (108 mL–1) and 1.0 v/v% (109 mL–1) tested in this 
microfluidic device demonstrate that the technique is suitable for such applications. 
2.3.6 Micron and submicron particle separation.  
There have been several recent investigations into separating micron and submicron 
particles using microfluidic platforms. [42,43] Among these, there are few reports of inertial 
focusing based particle separations in the micron and submicron range, but in one a spiral 
configuration was used to separate 3.2 µm and 2.1 µm particles, with 1.0 µm particles remaining 
unfocused.[22] At the same time, the separation of micron- and submicron-sized 
particles/bioparticles has significant utility. For example, the separation of rod-shaped bacterial 
cells (200 nm ×  2 to 8 µm) from virus particles (20 to 200 nm) has immediate clinical utility as 
part of sample preparation or purification. In this study, separation experiments have been 
carried out for particles ranging from 2 µm to 200 nm. Merged fluorescence images and intensity 
profiles of individual particles are shown in Figure. 2.10. In the 20 µm × 10 µm serpentine 
microchannel, 2 µm particles with 920 nm or 200 nm particles were studied to demonstrate the 
device’s ability to separate a typical bacterial cell from virus. At a modest flow rate (80 µL/min), 
the 2 µm particles (red) can be focused while the 920 nm particles (green) remain diffuse. 
Although the 2 µm and 920 nm particles are relatively close in size, this work represents the first 
time that these two sizes have been separated using inertial focusing. The 10 µm × 5 µm 
serpentine channel was then used to demonstrate the extraction of 200 nm particles (0.01 v/v%) 
from a mixture with 920 nm particles (0.01 v/v%). The 920 nm particles (green) equilibrated 
near the wall of microchannel, while the 200 nm particles (red) remain unfocused and evenly 
distributed. This approach can be used for separation of nanoparticles and bioparticles such as 




Figure 2.10 Micron and submicron particle separation. The left legends show the relative particles 
sizes and their corresponding florescence colors; the middle images are the merged fluorescence photos of 
two particles with difference sizes tested in the same microchannel at the same flow rates; the right plots 
are the intensity profiles of corresponding particles. 
 
2.3.7 Application to Bioparticles.  
Although rigid particles have been used here as a simple model to quantify inertial 
focusing effects on micron-size particles, bioparticles are typically not rigid and will deform 
under normal and shear stresses present in the flow field. To determine the effects of 
deformability on focusing, a suspension of Cyanobacterium Synechocystis sp. PCC 6803, with a 
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typical size of 2 µm[44] was introduced into a microfluidic chip with a 4 mm-long serpentine 
section. The cyanobacteria used here have been modified to express GFP.[45]  
 
Figure 2.11 The dependence of equilibrium particle streak location on particle deformability. (a) 
Schematics showing the layout of a serpentine microfluidic network for focusing for 2 µm spheres and 
cyanobateria.  This figure represents a top view of the design, and enlarged images for each region. There 
are five functional components: an inlet for the homogeneous suspension, a filter region to prevent 
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downstream channel clogging, an asymmetric serpentine channel to focus the particles, an isolation 
region to separate the particle stream from liquid media, and three collection outlets. Green dots represent 
cyanobacteria pathlines. (b) The two fluorescence intensity images on the left part are the focused GFP-
modified cyanobacteria and red fluorescent particles in the last curve. The white dashes represent the 
microchannel boundaries. Shown at right are fluorescence distribution histograms the 2 µm cyanobacteria 
and 2 µm particles across the width of the expanded isolation region leading to the three outlet channels. 
 
Figure. 2.11 shows fluorescence images of the 2 µm cyanobacteria (0.1 v/v%) and 2 µm 
fluorescent polystyrene spheres (0.1 v/v%) at the final curve of the focusing region. For both 
cases the flow rate was 300 µL/min. A scan of the fluorescence intensity across the downstream 
isolation channel width demonstrates distinct differences in the equilibrium position of these 
comparably sized particles. To quantify this shift, the distributions of 5,000 counts of both 2 µm 
red fluorescent polystyrene particles and cyanobacteria across the straight channel section are 
plotted. The cyanobacteria peak is 1.05 µm closer to the centerline than the polystyrene spheres. 
This shift might be the result of the bioparticle’s shape and deformability. Although most of the 
cyanobacteria are spherical in shape under quiescent conditions, they will form a transient 
ellipsoidal shape while undergoing division, as shown in Supplementary Figure. 2.12 The 
equilibrium position of nonspherical particles depends on their largest dimension, and results in a 
shift in equilibrium position away from wall[19], but in this system the effect of particle shape is 
expected to be small. The phenomenon of a shift in equilibrium positions for rigid and 
deformable particles has also been observed in a study done to classify different cell types using 
size and deformability as distinguishing markers.[46] The equilibrium position shift observed in 
this study also appears to be due to the deformability of the cyanobacteria.[17] Our result 
indicates that bioparticle equilibrium position in this serpentine micro channel for micron-sized 





Figure 2.12 An image of cultured cyanobacteria at 100× magnification. Although most of the 
cyanobacteria are spherical in shape under quiescent conditions, they will form a transient ellipsoidal 
shape while undergoing division.  
 
2.4 Conclusion 
In this study, a serpentine channel inertial focusing microfluidic system has been 
designed, fabricated and tested to demonstrate that inertial migration and Dean flow can be 
effectively and efficiently applied to achieve focusing of dilute suspensions. The focusing of 
micron-sized particles was accomplished through two advancements:  unique chip designs for 2 
µm and 0.92 µm particles and the use of a rigid, easy-to-fabricate polymer. At flow rates greater 
than 100 µL/min, very tight focusing of 2 µm particles and cells is achieved with this new chip, 
and even sub-micron particles are focused on the chip in a predictable manner. To increase the 
throughput-per-footprint for processing large samples, a number of factors were systematically 
investigated, including the effects of channel length, flow rate, and particle concentration on 
inertial focusing. To ensure focusing of the 2 µm particles and cells, the minimum length of the 
serpentine channel is found to be 4 mm, which is significantly shorter than in other published 
studies. In this 4 mm chip, it was observed that a stable, focused particle stream was achieved for 
all flow rates between 100 µL/min and 1,400 µL/min. A wide range of suspension 
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concentrations—from 0.01 v/v% to 1.0 v/v%—were tested in this chip, and it was found that 
0.01 and 0.1 v/v% suspensions were focused according to the standard definition. The highest 
concentration, 1.0 v/v%, where the particles are geometrically constrained from occupying a 
single pathline, suggests that a new definition for focusing be adopted that takes into account the 
minimum number of adjacent pathlines or trains required to accommodate all of the particles in 
the suspension. It was also demonstrated that the device is capable of separating disparate sized 
particles from one another, in particular, particles with sizes characteristic of bacteria and virus. 
Last, the focusing performance of the chip for deformable bioparticles has been investigated, and 
it is found that bacterial cells are focused as effectively as rigid particles. This study has pushed 
the boundary in inertial focusing to demonstrate the ability to isolate and separate smaller, 
micron- and submicron-sized particles, which opens up new applications for bacteria and 
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Although there is great opportunity and potential advantages for 
microalgae/cyanobacteria to replace significant quantities of petroleum-based fuels, these 
biofuels are not yet economically feasible at commercial scales. There remain a number of 
technical challenges to address in order for microalgae-based biofuels to become commercially 
viable [1]. These challenges include the production of sufficient algal biomass in bioreactors [2–
3], metabolic engineering of new strains of that are sufficiently robust and productive [4-5], 
creation of a low-cost method to harvest the microalgae/cyanobacteria [1,6–8], and development 
of a life-cycle assessment tool to evaluate the sustainability, economics, and scalability of the 
entire production process [9]. Among the different processing steps, cell harvesting is a critical 
economic component, because it can account for 20 to 30% of the total cost [1,7,8]. The primary 
challenge for harvesting is the need to concentrate a suspension of dilute, micron-sized cells 
from 0.5 g/L (0.05 wt%) to 200 g/L (20 wt%), after which lipid extraction may be carried out 
with relatively high efficiency [10,11].  Many harvesting methods have been developed, such as 
gravity sedimentation, filtration and centrifugation. However, the cost of the traditional 
harvesting methods still failed to be economically feasible. The costs for the dewatering 
technologies include both capital and operational costs (e.g., power consumption, maintenance). 
The base case capital costs of settling ponds, membranes, and centrifuges discussed in a National 
Renewable Energy Laboratory (NREL) report are $5.80/(m3/day), $178/(m3/day) and 
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$478/(m3/day), respectively [1]. Thus, viable harvesting methods that are economically feasible 
and scalable for commercial use still need to be identified. Recently, there are a number of new 
or improved technologies under development, such as electrocoagulation [11], magnetic 
separation [7], and ultrasonic separation [1]. The investigation of emerging technologies may 
yield a harvesting strategy that meets needed efficiencies, costs, and longevity.  
Microfluidic platforms provide a set of fluidic unit operations that enable the 
miniaturization, integration, and parallelization for specific applications. In contrast to isolated 
application-specific solutions, microfluidic platforms are designed for ready integration within a 
well-defined fabrication technology, allowing easy, fast, and cost-efficient implementation for a 
wide variety of different applications [12–14]. In addition, microfluidics technology is readily 
scalable to high volume, high throughput processes due to its intrinsic properties of 
miniaturization and parallelization [15–18]. An important characteristic of these platforms is that 
validation of a single microfluidic device’s working principles and subsequent optimization of its 
operating conditions is sufficient to demonstrate intrinsic scalability of the platform via a 
multilayer, parallelized design.  
Inertial focusing in microfluidic devices is an emerging and robust approach to 
concentrate and isolate particles from a liquid medium based on size. The general approach 
capitalizes on microscale hydrodynamic physics resulting from flow through microchannels [19–
22]. Due to the advantages of low device fabrication and operation costs, and throughput scalable 
to macroscale system requirements, inertial focusing microfluidics has been demonstrated as a 
promising approach for the continuous concentration of mammalian cells, and has replaced the 
need for centrifugation [23]. However, in contrast with most of the devices designed for 
operation with mammalian cells, which typically have a length scale greater than 10 µm, 
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concentrating cyanobacteria-sized bio-particles (~2µm in size for Cyanobacterium Synechocystis 
sp. PCC 6803) remains a challenge using inertial microfluidics. Our previous work has 
demonstrated that inertial focusing could be applied to efficiently focus and isolate polystyrene 
microspheres with a size comparable to Cyanobacteria, in devices where substantial changes 
were made in microchannel design and fabrication [19–22].  
In this study, a unique approach is presented that integrates microfluidics and 
cyanobacteria concentration, and which has significant potential for process throughput scale up 
that is required to meet large-scale biofuel production needs. The critical feature of this 
technology is its intrinsic scalability. Although the focus of this study is proof of principle, 
fabrication of a massively parallel microchannel network for processing large volumes, with 
multiple sequential stages for increased concentration factors, is anticipated to be a 
straightforward process. In this study, to demonstrate and quantify the new approach, the 
mechanism for concentration of 2 µm cyanobacteria is presented. Then, the specific design for 
harvesting cyanobacteria is described in detail and the fabrication steps for this polymeric 
prototype are outlined. High-speed camera images of the concentration and cell isolation process 
have been recorded, and were subsequently used to analyze cyanobacteria distribution patterns 
across the microchannel width. The associated effects of operating parameters such as flow rate 
and inlet suspension concentration were characterized based on the data from the video; from 
that data the harvest efficiency was evaluated using the measured concentration factor and 
recovery efficiency. Since the cost of algal harvesting is a major factor in the overall economics 
of large-scale operation, device fabrication cost and energy consumption (pumping cost) have 
been calculated and presented in this article.  
58 
 
3.2 Material and methods 
3.2.1 Device Fabrication 
The inertial focusing microfluidic device was fabricated using soft lithography [24] with 
thermoset polyester (TPE). First, the channel pattern was designed using AutoCAD 
(AutoCAD 2014, AutoDesk, Inc).  Following that step the CAD design was printed at 20,000 
dots per inch (dpi) onto a photomask.  Then, a mold was fabricated in a single step process under 
a UV lamp (OmniCure S2000, Lumen Dynamics Group Inc., Ontario, Canada).  
Before fabricating the microfluidic device, the mold was exposed to 
hexamethyldisilazane (HMDS) (Sigma-Aldrich, MO, USA) for 4 h at 60°C. A well-mixed and 
degassed resin (TAP Clear-Lite Casting Resin, CA, USA) with MEPK catalyst (TAP plastics, 
CA, USA) (resin: catalyst = 10:1 w/w) was poured on the mold and surrounded by a piece of 
PDMS, which confined the mix within the mold. A piece of transparency film (3M Scotchpak 
9744, MN, USA) was used as a top cover over the mix to ensure a flat surface. Then, the mold 
with resin was baked for 8 min at 60°C, after which the TPE replica was peeled from the master. 
A biopsy punch (Technical Innovations, FL, Inc. USA) was used to create 1.5 mm diameter inlet 
and outlet ports. 
To generate an enclosed channel, the TPE replica and a piece of glass substrate (or a 
piece of coverslip for high-speed camera imaging) are placed in a plasma chamber and pumped 
down to 200.3 mTorr, followed by purging with O2 gas for 20 s. Then the pieces are exposed to 
oxygen plasma (Plasma Etch, NV, USA) for 1 min. After removal from the chamber, the TPE 
piece is brought into contact with the glass, and left to cure in a 60°C oven for 5 min. To achieve 
pressure-driven liquid flow of the suspensions in these TPE-glass hybrid devices, tubing 
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connectors (Nanoport, WA, USA) are attached to the ports on the chip using room temperature 
cured epoxy.  
3.2.2 Cyanobacteria Source and Cultivation 
Cyanobacterium Synechocystis sp. PCC 6803 was grown in liquid BG-11 medium [25]. 
The strain was inoculated at an initial concentration of 106 mL–1 and cultured in a 250 mL 
Erlenmeyer flask with 50 mL culture medium in an INNOVA 44 Incubator Shaker (New 
Brunswick Scientific, NJ, USA) at 30°C and a speed of 225 rpm, and an average light intensity 
was 100±9 µmol·m–2·s–1. These 50 mL suspensions were cultured to a concentration between 
2×108 and 5×108 mL–1 for future use, at which time the culture was diluted or concentrated to the 
desired cell density for the inertial focusing tests.  
3.2.3 Experimental setup and method 
The inlet of the device was connected to one syringe using Tygon tubing. The 
cyanobacteria culture in a syringe with known concentration (2.4×107 mL–1; 2.4×108 mL–1 or 
2.4×109 mL-1) was delivered into the inertial focusing microfluidic chip at specified flow rates 
using a syringe pump (New Era Pump Systems, NY, USA) to generate stable and continuous 
volumetric flow. The inlet concentration of the cyanobacteria suspension was measured with a 
hemocytometer (Hausser Scientific Partnership, PA, USA) three times. 
3.2.4 High-speed Imaging and data analysis 
The TPE-glass hybrid device was mounted onto the stage of an Olympus IX 71 Inverted 
optical Microscope (Olympus, Japan), and connected to a high-speed camera (Fastcam 
SA3, Photron, USA). Using the high-speed camera the cyanobacteria concentration process in 
the isolation region of the chip was recorded at 2,000 frames per second (495 μs interval) with a 
5 μs shutter speed. After images were acquired and stored, analysis conducted using ImageJ 
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(http://rsb.info.nih.gov/ij/) counted the number of cyanobacteria in each frame and recorded the 
horizontal xy location of each cell. Performance of this chip for cyanobacteria harvesting was 
assessed using the measured recovery efficiency and concentration factor.  
3.3 Theory 
The concept of inertial migration has been introduced in this discussion to provide a 
qualitative background for the physics of system operation, and to indicate how modifications 
may be made to existing design to facilitate focusing of micron-sized cyanobacteria. The first 
studies of inertial migration involved macro-scale systems in the laminar flow regime, and were 
demonstrated by Segré and Silberberg [26] in 1961. Their experiments in tubes of circular cross 
section showed that rigid, 1 mm diameter spherical particles migrated to an annular region 
located approximately six-tenths of the distance from the axis to the wall in a 1 cm diameter 
cylinder. Di Carlo et al. first carried out studies to accomplish inertial focusing of smaller 
particles in a microfluidics format under laminar flow conditions [27]. Those results 
demonstrated the potential for concentrating micron-sized particles/bio-particles in a 
microfluidic chip without externally applied forces or fields.   
In a two-dimensional pipe flow such as that shown as shown in Fig. 1A, particles in 
laminar flow experience a force resulting from gradients in the parabolic velocity profile, which 
is called the shear gradient lift force (FSL), pushing particles away from channel centerline. At the 
same time, the channel wall induces a surface-effect lift force (FWL), which moves particles away 
from the channel or tube wall [20]. The net force is referred to as the lift force. When these two 
forces balance one another the particles are located in a stable equilibrium position within the 




where ρ is the liquid density, Um is the maximum channel velocity, a is the particle 
diameter, fc is a lift coefficient, and Dh is the hydraulic diameter of the channel, defined as Dh 
=2hw/ (h + w), where h and w are the height and width of the channel cross-section, respectively. 
This equation illustrates the strong dependence of lift force on particle diameter, specifically, to 
the fourth order. Because of this dependence on a, to focus smaller particles in a given geometry, 
much higher Um and a reduced microchannel cross-sectional area are required compared to other 
devices for larger bio-particles, such as those used with mammalian cells. In straight, square 
channels (Fig. 1B), particles focus to four equilibrium regions centered on each face. In straight 
rectangular channels (Fig. 1C), particles migrate to two equilibrium positions, which are located 
at the middle of the long channel faces. For optimal separations in this study, even fewer 
equilibrium positions are needed in order to maximize the concentration factor of the product 
stream. To accomplish this reduction in the number equilibrium cell locations, inertial focusing 
is coupled with Dean flow, which may be generated through use of a curved channel (Fig. 1D) 
that results in a mismatch of the velocity magnitude in the downstream direction between the 
center and near-wall regions [20]. Dean drag (FD) scales as FD ~ρUm2aDh2/r, where r is the 




Figure 3.1 Inertial lift forces. (A) In two-dimensional or axisymmetric geometries, particles in 
flow experience opposing forces associated with shear gradient lift (FSL) and wall-effect lift 
(FWL) that balance when the particles reach equilibrium lateral positions. (B) In a square channel, 
the randomly distributed inlet suspension will be focused into four equilibrium regions centered 
at each face. (C) For rectangular channels, the randomly distributed particles migrate to two 
equilibrium positions which are located near the middle of the long channel faces. (D) Dean flow 
creates two counter-rotating vortices (white arrows) perpendicular to the primary flow direction; 
red arrows show the overall effects of both lift force and Dean drag (location 1: lift force – Dean 
drag; location 2: lift force + Dean force; location 3: only Dean force; location 4: only Dean 
force).  
 
3.4 Results and Discussion 
3.4.1 Design of the inertial focusing device for cyanobacteria harvesting 
As mentioned above there are a number of challenges when concentrating small particles 
such as cyanobacteria using an inertial migration approach. First, because cyanobacteria (2 µm) 
are small relative to mammalian cells (≥ 10 µm), a reduced microchannel cross-section is 
required because of the non-linear dependence on cell size, which complicates the design and 
fabrication of correspondingly small microchannel dimensions. Another important challenge is 
the high pressure drop required to achieve flow rates (as represented by Um) necessary to focus 
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cyanobacteria under conditions that may be scaled up for commercial use. In particular, these 
pressure drops become problematic when standard materials are used to fabricate the 
microfluidic networks. An example of such a material is Poly(dimethylsiloxane) (PDMS), which 
is a relatively soft elastomer used in many microfluidic chip applications. In that device, 
however, that material exhibits large deformation of the microchannel cross-section when flow 
rates are increased to enhance particle focusing, with the result that the particles are actually de-
focused. Consequently, fabrication procedures for this device have been modified to allow use of 
standard lithographic techniques with a different polymeric material, thermoset polyester (TPE), 
which is a polymer alternative to PDMS with similar fabrication procedures but higher rigidity 
for high-pressure flow applications. TPE resin is a readily acquired, inexpensive feedstock, 
currently costing $84.25 per gallon (TAP Plastics Inc., CA, USA) As a reference point, a single 
chip in these studies requires only 1 mL of the TPE resin. Thus, the research cost of raw 
materials is $0.02 per chip of 10 parallel channels, and bulk use of material for large-scale 
parallelized designs can be expected to further lower the cost. Importantly, it is anticipated that 
the use of this rigid polymer will serve as an intermediary for the smooth transition from 
laboratory devices to other thermoplastics more ideally suited for commercial use [29]. 
The use of serpentine channels provides an efficient geometry for inertial focusing, and it 
has been demonstrated that less linear distance is required as compared to straight channels, plus 
the fact that the serpentine geometry is readily parallelized for scale up to high throughput 
operation. The microchannel design, which is optimized for cyanobacteria harvesting, is shown 
in Fig. 2A. There are five functional components: an inlet for the homogeneous suspension, a 
filter region to prevent downstream channel clogging, an asymmetric serpentine channel to focus 
the particles, an isolation region to separate the particle stream from liquid media, and three 
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collection outlets. The microchannel height is a uniform 10 µm, which was necessary to focus 
particles as small as cyanobacteria. The curved channels have a width of 20 µm on the small 
radius turns and a width of 80 µm on the large radius turns. The entire serpentine region is 4 mm 
in extent. The width of the isolation region is 150 µm, and there are outlet three branches 
connected to that region. From top to bottom in Fig. 2C, the branch widths are 30 µm, 45µm and 
75 µm. Based on this isolation region and outlet channel configuration, the maximum possible 
concentration factor is 3.33. Using three-dimensional computational fluid dynamics simulations, 
it was predicted that outlet 2 should contain the product stream, and outlets 1 and 3 would, 
ideally, collect particle-free waste streams. Video from the high-speed camera showing the 
cyanobacteria concentration process in the isolation region is shown in a SI Video (see 
supplementary information Video). The camera captured images at 2000 fps, and this rate is 




Figure 3.2 Design of the microfluidic device for concentrating cyanobacteria. (A) Top view of 
the design and enlarged images for each region. There are five functional components: an inlet 
for the homogeneous suspension, a filter region to prevent downstream channel clogging, an 
asymmetric serpentine channel to focus the particles, an isolation region to separate the particle 
stream from liquid media, and three collection outlets. Green dots represent cyanobacteria 
pathlines. (B) Cross section view of cyanobacteria focusing in the straight channel after the last 
curve. (C) Detailed view and scale of the isolation region. The A1 and A3 regions fed outlets 1 
and 3, which carried the waste streams, and A2 fed outlet 2, which was intended for collecting 
the concentrated cyanobacteria product stream. 
 
3.4.2 Effect of flow rate on cyanobacteria distribution 
Fig. 3 shows the histogram (left) and heat map (right) of cyanobacteria distribution across 
the isolation part of the microchannel (150 µm) for an inlet concentration of 0.1 vol-% (2.4×108 
mL–1), for flow rates between 100 µL/min and 700 µL/min. The distribution of lateral 
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cyanobacteria cell positions can be depicted using a histogram plot as well as a heat map. Each 
cell’s horizontal (x,y) position was measured from a single image stack, and then all positions 
from all 2000 image stacks were plotted onto a single histogram and heat map. The histogram 
allows for the visualization of the cyanobacteria distribution across the microchannel relative to 
the locations of the three outlets. Fitted Gaussian curves, which are used to quantify the width of 
the distribution, are shown as red dotted lines for all histograms. At the same time, the heat map 
enables qualitative visualization of cyanobacteria locations in the isolation region of the 
microchannel as shown in Fig. 3B. Flow rate played a critical role in the distribution of 
cyanobacteria across the 150 µm microchannel width. Cyanobacteria distribution histograms 
show increasing focusing efficiency at higher flow rates, that is, the width of the fitted Gaussian 
profiles become narrower. As flow rate, and thus velocity increase, inertial forces increase in 
magnitude relative to viscous forces, with the result that the shear gradient lift force and wall-
effect lift force both increase and confine the particle stream to a narrower region. This effect 
may be quantified using the Reynolds number, which is a dimensionless parameter that indicates 
the significance of inertial forces with respect to viscous forces [20]. It is desirable to achieve as 
high degree of focusing (as narrow a distribution) as possible, because that condition will result 
in the highest possible recovery efficiency and concentration factor. Here, recovery efficiency is 
defined as the ratio of the number of cyanobacteria in the product channel to the total number of 
cyanobacteria. The concentration factor is defined as the ratio of output cyanobacteria 
concentration to input cyanobacteria concentration. Recovery efficiency and concentration factor 
are important indices used to evaluate the performance of the algal harvesting platform.  
The horizontal location of the profile peak also depends on the volumetric flow rates, 
such that it shifts further away from the centerline toward the side wall as flow rate is increased. 
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The reason for the shift is that, at higher flow rates, the increase in the shear gradient lift force 
(FSL) becomes dominant, and pushes the cyanobacteria nearer to the side wall [20]. At the same 
time, the Dean drag force acting on the particles is proportional to the square of the maximum 
velocity in the curved channel region, with the result that the cyanobacteria experience a stronger 
Dean drag directing them toward the inner wall as flow rate (or Reynolds number, Re) is 
increased [30]. These two effects result in the observed shift in the location of the peak 
cyanobacteria distribution toward the side wall at higher flow rates (Re). Knowledge of the 
location of the focused cyanobacteria stream is a key factor in the design of the microfluidic 





Figure 3.3 Cyanobacteria distribution across the isolation region at different flow rates, for an 
0.1 vol-% inlet concentration. (A) The histogram shows the distribution of cyanobacteria in 
regions A1, A2, and A3, where fitted Gaussian curves are shown as red dotted lines for all 




3.4.3 Effect of input concentration on cyanobacteria distribution 
To use this platform to concentrate the cyanobacteria culture from its initial dilute state to 
a suspension with a hundred- to thousand-fold increase in cell density, it is necessary for the 
microchannel configuration to successfully focus a wide range of suspension concentrations. The 
inertial focusing approach has been demonstrated when suspension concentrations are low (< 
0.01 vol-%) [27], but device performance at higher cells concentrations has yet to be quantified. 
In this study a wide range of cyanobacteria culture concentrations—0.01 vol-%, 0.1 vol-% and 1 
vol-%—have been investigated using this microfluidic concentrator platform. As expected, the 
degree to which the cell suspension was focused depended on the initial concentration. In the 
studies, a high-speed camera recorded the cyanobacteria distributions across the width of the 
isolation region for different cyanobacteria suspension concentrations. In those experiments the 
flow rate was held constant at 300 µL /min. A video of this process with a 0.1 vol-% 
cyanobacteria suspension inlet concentration is shown in the SI Video (see the supplementary 
information Video). Fig. 4 shows the histogram (left) and heat map (right) of the cyanobacteria 
distributions across the channel width. As the concentration increased from 0.01 vol-% (2.4×107 
mL–1) to 1 vol-% (2.4×109 mL–1), the locations of the maximum cell densities were similar, 
approximately 48 µm (48.8 µm for 0.01 vol-%, 47.4 µm for 0.1 vol-%, 48.3 µm for 1 vol-%), 
which confirms the theoretical result that, for given particle size and channel geometry, the flow 
rate (or, Re) determines the location of the profile peak.  As concentration increases from 0.01 to 
1 vol-%, the FWHM (full width at half maximum) of the cyanobacteria cell distribution 
increases from 7.79 µm to 19.9 µm, where the FWHM was calculated from a fitted Gaussian 
distribution to the cyanobacteria distribution histogram. All cyanobacteria profile widths are 
greater than 3 times the cell diameter (2 µm), and this spread is due to the decrease in velocity 
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from the focusing region to the expanded isolation region; there is a measurable defocusing 
effect that occurs which impacts achievable concentration factors. On top of this phenomenon, 
the streak widths reflect a concentration dependence, which may be explained as follows: first, 
the number of cyanobacteria per unit length of the channels is fixed, based on the initial 
concentration; at lower concentrations it is theoretically possible for all cells to be focused onto a 
single pathline, but at the highest concentration, 1 vol-%, this is no longer the case [31]. Second, 
at higher concentrations there is increased inter-particle interactions, which tend to be repulsive 
due to surface charge effects [20]. Although the salt in the media mitigates surface charge 
effects, the close proximity of the cells upon focusing also tends to defocus the particle trains. 
Thus, it is necessary not only to know the location of the focused particle streams, but also to 
take into account the streak broadening in order to ensure as a high recovery efficiency as 
possible. The isolation region design used in this study works well for cyanobacteria suspensions 




Figure 3.4  Cyanobacteria distribution across the isolation region for different inlet 
cyanobacteria suspension concentrations, at a flow rate of 300 µL/min. (A) The histogram shows 
the distribution of cyanobacteria in A1, A2 and A3 regions, and fitted Gaussian curves are shown 
as red dotted lines for all histograms. (B) Heat map for the corresponding histogram on the left. 
 
3.4.4 Effect of flow rate on concentration effectiveness 
To quantify the ability of this inertial migration based microfluidics platform to 
concentrate cyanobacteria, the effect of flow rate on cyanobacteria recovery efficiency and 
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concentration factor were investigated, and the results are shown in Fig. 5 for a 0.1 vol-% inlet 
suspension concentration. Flow rates had a positive influence on cyanobacteria harvesting, 
specifically, recovery efficiencies increased as the flow rate was increased up to 500 µL/min, 
with a decrease in efficiency at 700 µL/min. All of the recovery efficiencies were above 
96.3±0.3% (mean ± standard deviation), with the highest at 98.4±0.2%. Concentration factor was 
found to follow the same trend as a function of flow rate. Based on outlet channel geometries, 
the maximum possible concentration factor for the current design is 3.33, and the experimental 
results yielded concentration factors above 3.2 for all the flow rates that were tested. The 
decrease in both recovery efficiency and concentration factor at the highest flow rate, 700 
µL/min, can be explained by the distribution of the cyanobacteria across the microchannel. It 
was observed that, although the width of cyanobacteria streak is narrower at 700 µL/min than at 
the lower flow rates, its location shifts toward the side wall. As a result, some cells were directed 
into outlet 1 instead of outlet 2. If the outlet channel geometries were redesigned to take this shift 
into account, higher recovery efficiencies and concentration factors would be achieved.  
Figure 3.5 Effect of flow rate on chip concentration performance of Cyanobacterium 
Synechocystis sp. PCC 6803. (A) Effect of flow rates on recovery efficiency. (B) Effect of flow 




3.4.5 Effect of inlet cell density on concentration effectiveness 
The Cyanobacteria inlet suspension concentration is also a key factor in the harvesting 
process. If the current single channel design were operated in series, such that the inlet 
concentration is the outlet product concentration from the previous stage, then there is a 
monotonic increase in suspension density with each pass or stage. In this manner an initially 
dilute suspension can be concentrated 120-fold after four stages. To ensure successful operation 
over a wide range of cell densities, the platform was tested with different inlet concentrations 
ranging from 0.01 vol-% (2.4×107 mL–1) to 1 vol-% (2.4×109 mL–1) to quantify its performance. 
As opposed to flow rate, the suspension density had a slightly negative effect on harvesting 
efficiency, as shown in Fig. 6. The recovery efficiency and concentration factor both dropped 
slightly as concentration increased two orders of magnitude. The average drop in recovery 
efficiency was 2.2%, and at the same time, the average reduction in concentration factor was 
0.073, or 2.4%. These performance metrics demonstrate that there is very small degradation in 
performance for a wide range of suspension concentrations, and the basic device design is 
suitable for implementation in a series format to obtain a concentrated suspension in a multi-pass 
configuration. Note that concentrations below 0.01 vol-% were not investigated, because it is 
known that device operation only improves at lower concentrations [20]. The current device is 
relevant as a first stage dewatering technology, since it can process large volumes if thousands to 
tens of thousands of microchannels operate in parallel, and it can achieve overall concentration 
factors greater than 100 if operated in series. Also, work continues on the addition of functional 





Fig 3.6 Effect of inlet suspension concentrations on chip performance at 300 µL/min for 
Cyanobacterium Synechocystis sp. PCC 6803. (A) Effect of inlet concentration on recovery 
efficiency. (B) Effect of inlet concentrationss on the concentration factor.  
 
3.4.6 Power consumption 
One essential component of the biofuel processing stream is power consumption, and this 
aspect has been a major roadblock on the path toward economic viability. The results presented 
above conclusively demonstrate that the inertial focusing based microfluidic concentrator (µFC) 
is capable of continuous operation for harvesting cyanobacteria with a high recovery efficiency. 
As a complement to those studies, power consumption calculations have been carried out to 
quantify the energy required per unit volume of suspension in order to determine whether the 
energy consumption is comparable to reported data for other harvesting technologies. In practice, 
the major consumption of power in this microfluidics platform comes from the fluidic pressure 
drop in each microchannel.  The pressure drop down the length of a channel may be computed as 
[32] 
                                                                                                                             (2) 
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where  is the volumetric flow rate,   is the hydraulic resistance to flow within the 
microchannel, and  is the pressure drop in each microchannel. The resistance  can be 
calculated as [32] 
(3) 
The power consumption, or shaft work (W) can then be determined as 
                                                                                                                      (4) 
From Eq. (4) it may be seen that the energy required per unit volume, or , is just 
equal to the pressure drop. With the advent and now ubiquitous use of soft lithography 
techniques, it is straightforward to construct multi-layer, massively parallel microfluidic 
networks. In a parallel microchannel system, the pressure drop of a single channel is equal to the 
overall pressure drop of the whole system. Therefore, there is an advantage to implement a 
parallel large-scale design to increase the throughput without compromising the low power 
consumption per unit sample volume. Of course, the power consumption per unit volume will 
increase, more or less linearly, in a serial system, where the number of sequential stages will 
determine the overall concentration factor to be achieved. The calculated pressure drop, power 
consumption, and energy consumed per unit volume as a function of serial stages (concentration 
factor) are shown in Table S1. Table 1 shows the calculated power consumption per unit volume 
for different concentration factors in the cyanobacteria microfluidic concentrator as well as for 
other technologies for which power consumption data are reported [33]. The single-microchannel 
flow rate used in Table 1 is 100 µL/min, which is an intermediate flow rate for purposes of 
demonstration; lower (10 µL/min) and higher (1000 µL/min) flow rates can also work in this 
system (data not shown). The calculated power consumption of the microfluidic concentrator is 
comparable to other reported centrifuge methods, with even lower energy consumption than a 
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decanter bowl centrifuge at the same concentration factor. The energy consumption per unit 
volume of our microfluidics device with the current flow rate (100 µL/min) is comparable or 
even lower than conventional methods. But this is still not optimal based on the challenging 
target of being less than $0.013/GGE (GGE: U.S. gallon of gasoline equivalent), as set by the 
National Alliance for Advanced Biofuels and Bioproducts (NAABB) in 2009. Every 
kWh/m3 consumed at the first stage of harvesting contributes approximately $1/GGE to the cost 
of algal biofuel [1]. This NAABB target necessitates reducing the energy requirements of the 
microfluidics approach by at least a factor of 10 relative to the Table 1 values. A ten-fold 
decrease in power requirements can be realized if the flow rate is reduced to 10 µL/min, which 
would be significantly lower than other reported power consumption per unit volume and 
approaching the algae harvesting energy consumption targets set by NAABB. Based on these 
simple power consumption analyses, it may be concluded that the microfluidic concentrator 
approach is a promising alternative for harvesting cyanobacteria for biofuel production.  
3.4.7 Capital cost 
The cost of fabricating a module capable of processing 300 L/h of cyanobacteria 
suspension to obtain a concentration factor of about 120 is considered here. Regarding the 
physical size, to process 300 L/h at 100 µL/min/channel, it would require 50000 parallel 
channels. Given the channel geometries used here, a 50-layer device with 1000 parallel 
microchannels per layer would have a width of 0.5 m, a height of 0.1 m, and length (in the 
direction of flow) of 0.01 m. That length represents a single pass through the concentrator, so 
sequential processing would require a module length of 0.01N, where N is the number of passes 
or concentration steps. If this device is constructed using thermoset polyester, as was done in this 
proof-of-concept study, the total cost of materials (retail) would be $120, including the silicon 
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wafer mold, photoresist, and monomer. A pump capable of processing this volumetric flow rate 
could be purchased for less than $500. If we assume that the microfluidic module to be replaced 
4 times a year due to fouling or mechanical failure, then the capital cost of the proposed system 
would be $0.40/(m3/day). This capital cost is less than one tenth of the settling pond, which has 
the lowest base costs of traditional harvesting approaches discussed in the introduction section. It 
must also be noted that there is a trade-off between the capital cost and the energy consumption 
for the microfluidic concentrator. As the proposed scale-up strategy is linear, capital costs would 
increase linearly with decreasing flow rate. For example, the capital cost would be $4.0/(m3/day) 
to process 300 L/h at 10 µL/min/channel, but the energy (pumping) costs would decrease by a 
factor of 10. 
Table 3.1 Power consumptions of microfluidic concentrator and other concentrating approaches 
 
Harvesting technology Concentration factor 
(vol. in/vol. out) 
Energy consumed per unit volume 
(kWh·m–3) 
Decanter bowl centrifuge [33] 11 8.0 
Self-cleaning, disc-stack centrifuge [33] 120 1.0 












Table 3.2 The calculated pressure drop, power consumption and energy consumed per volume 
unit based on increased concentration factor. 
 
Concentration factor 





Energy consumed per volume unit 
(kWh·m–3) 
3 5.83×106 485.9 1.6 
11 1.17×107 971.7 3.2 
36 1.75×107 1457.6 4.8 
118 2.33×107 1943.5 6.4 
390 2.92×107 2429.4 8.1 
 
3.5 Conclusion 
A low cost, miniaturized microfluidic concentrator for cyanobacteria harvesting has been 
developed. The platform design is based on concepts from inertial migration and Dean flow 
theories, and it has the potential to be applied at commercial scales for harvesting of 
cyanobacteria at initial concentrations of 0.1, 0.01, or even 0.001 vol-%, with a final product 
stream that may have cell densities as high as 3.2 vol-%. Demonstrated recovery efficiencies in 
this device exceed 96%, and can reach 98% under continuous operating conditions, while at the 
same time resulting on concentration factors approaching the theoretical maximum. This device 
is versatile, and it has been shown that higher recovery efficiencies and concentration factors 
may be achieved at higher flow rates and with optimized outlet channel geometries. Importantly, 
this device is tailored to Cyanobacteria concentration, but is by no means restricted to this 
microorganism. Many other microalgae or bacteria could be concentrated by adjusting the 
microchannel geometries. Compared with the capital cost of other microalgae/cyanobacteria 
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harvesting technologies, the cost of device is very low (~$0.002 per channel), there are no 
residual chemicals in the harvested cyanobacteria or media, and there are no moving parts in the 
device itself. In addition, volumetric power consumption of this microfluidic concentrator is 
comparable and even lower relative to other traditional approaches. Scale up of this microfluidics 
concentrator is conceptually straight forward through parallel microchannel configurations and 
multilayer (stacking) operation. Additional opportunities to lower the microalgae harvesting 
costs using microfluidics technology lies in the trade-off in the inverse relationship between 
operating energy requirements and capital cost. Further studies using lower flow rates in the 
microfluidics device would be beneficial in reducing the overall cost and approaching the 
NAABB target. This microfluidic concentrator is a promising alternative approach for harvesting 
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4.1 Introduction  
As universal biological information storage entities, nucleic acids (DNA and RNA) are 
unique biorecognition molecules, and the detection of pathogen genomic DNA or RNA provides 
one of the most reliable methods for viral infectious disease diagnostics. Emerging and 
remerging infectious pathogens, such as Ebola, Middle East Respiratory Syndrome (MERS), 
West Nile, dengue and Zika viruses create a strong need for a low-cost, point-of-care (POC) 
diagnostic platform that would enable rapid and sensitive pathogen detection[1–4]. Early and 
accurate detection of viral infectious diseases is of crucial importance in preventing epidemic 
disease outbreaks as well as in improving the efficacy of POC diagnostic technologies [5,6]. In 
use since the early 1990s, quantitative real-time polymerase chain reaction (qPCR) amplification 
has been a gold standard in viral diagnostics [7,8]. While qPCR offers high specificity with low 
limits of detection, it and other similar existing diagnostic methods have their drawbacks, such as 
the use of expensive devices for repeated thermal cycling, specialized non-reusable reagents, the 
need for sensitive fluorescence detection optics, and laborious assay preparation steps requiring 
trained personnel [9].   For example, a typical qPCR will require highly trained technicians 4 to 8 
hours from sample preparation to completion using reagents such as specific TaqMan probes and 
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matching master mixes with reverse transcriptase enzymes and DNA polymerase, costing up to 
hundreds of dollars per assay depending on sample number and origin. Consequently, such 
analytical methods do not align with the need for a rapid, inexpensive, highly specific and 
sensitive point-of-care platform [5,6,10].  
One of the cost-effective alternatives to PCR-based detection of pathogen genomic DNA 
relies on measurement of electrical property changes (resistance, capacitance, and complex 
impedance) due to DNA-DNA hybridization at probe-target binding sites without labeling. Such 
a sensing modality has been used successfully to detect specific DNA molecules in complex 
mixtures in a number of different assays, making it attractive for reliable classification of target 
DNA [11–14]. Electrode configuration and geometry can have a significant effect on sensor 
performance [15]. One of the widely used electrode configurations, especially for sensors 
measuring capacitance changes due to DNA-DNA hybridization (capacitive biosensors), is the 
interdigitated microelectrode. Microelectrodes are often made using modern photolithographic 
and deposition techniques on glass, silicon, or other solid substrates [15–17]. When they are 
tightly integrated with the back-end measurement circuits, they have significant advantages over 
conventional carbon-based electrodes [18] for analytical measurements, such as low resistance, 
high signal-to-noise ratio, rapid attainment of steady state, and the use of small solution volumes 
[19–21].  
Operating modalities of biosensors using interdigitated electrodes (IDEs) can be non-
faradaic [22] or faradaic [23]. The biosensor presented in this paper operates in the non-faradaic 
mode based on changes in capacitance between interdigitated electrodes to indicate molecular 
binding events at the electrode surface. Biosensors operating in the faradaic mode are often 
based on electrochemical impedance spectroscopy (EIS) [24,25] by measuring electron transfer 
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resistance and double layer capacitance within a frequency range. Comparing to capacitive 
biosensors, biosensors based on EIS have been widely explored for their ability to capture 
complex resistance changes due to binding events at biosensor’s electrode sites. However, they 
are more complex from an electronics and experimental protocol perspective, requiring a wide-
range frequency sweep and the use of a potentially hazardous redox couple (e.g. Fe(CN)6 3-/4-) 
for measuring faradaic current. With the simplicity of measuring capacitance change between 
electrodes due to DNA-DNA hybridization between targets and probes, combined with low limit 
of detection (LOD) and high specificity, the results from this paper show that label-free 
capacitive biosensors have the potential as a baseline technology for low-cost, low-power, easy 
to use rapid detection POC platform [26]. 
To date, capacitive biosensors developed for DNA/RNA classification and pathogen 
detection have focused on improving the electrode surface modification process, achieving better 
transducer sensitivity, and increasing detection circuit sensitivity and signal-to-noise ratio (SNR). 
Berggren et al. [27] reported a label-free capacitive detection method for DNA detection, and 
pushed the limit of detection down to 25 complementary DNA targets per µL. Moreno-Hagelsieb 
et al. [28] demonstrated the use of an inexpensive Al/Al2O3 hybrid electrode to achieve good 
sensitivity. Guiducci et al. [29] elucidated a number of important details relevant to charge-based 
capacitance measurements, and provided insights into CMOS compatible implementation for 
integrated electronics. Stagni et al. [22] demonstrated a capacitive biosensor design with a 
detection range of 330 pF to 10 µF with good linearity. Lee et al. [30] developed CMOS circuitry 
based on charge/discharge theory for detecting capacitive signals to demonstrate its ability to 
detect 2 nM of target nucleic acid from H5N1 Influenza viruses. Qureshi et al. [31] achieved 
multiplexed detection using an interdigitated electrode array, with 25 pg/mL sensitivity to the 
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complementary target. Eberhardt et al. [32] reported a bio-inspired artificial whisker to monitor 
fluid motion using capacitive sensing.  Kallempud et al. [33] proposed a capacitance detection 
method using Fourier transform infrared spectroscopy (FT-IR) at high frequency, and achieved a 
1ng/mL detection limit. Wright et al. [34] demonstrated an ultra-sensitive read-out circuit for 
measuring capacitance changes capable of sub-fF detection limit. 
However, even with more than a decade of progress in capacitive biosensor development, 
significant challenges remain. A number of studies [31,35] reported poor sensor-to-sensor 
reproducibility. Non-uniformity of the self-assembled monolayer (SAM) and the covalently 
attached DNA probes on the sensor surface is a major contributing factor to poor sensor-to-
sensor reproducibility. Sensor surface cleanliness greatly affects the uniformity of SAM layers 
[36]. Covalently attached ssDNA probes are largely affected by the presence of common 
contaminants in commercial thiolated DNA probes [30].  The lack of emphasis on electrode 
cleaning prior to assay functionalization may have also contributed to significant variations of 
the reported results.  Stagni et al. [22] elucidated the importance of electrode surface cleaning in 
order to achieve uniform covalent binding of thiolated DNA probes. In addition, the total surface 
area of microelectrodes and the geometric relationship between two electrodes in a biosensor are 
other factors which directly affect sensor sensitivity and reproducibility, as measured capacitance 
output represents averaged values from all the fingers of the microelectrodes [37].  
Here, a label-free, affinity-based capacitive IDE sensor is developed for unamplified 
nucleic acid detection, with high sensitivity and reproducibility. The proposed platform 
technology uses capacitance changes resulting from the solid-phase hybridization of nucleic acid 
targets with ssDNA probes immobilized on microelectrodes as the means of detection and 
identification.  A 24-nucleotide DNA probe and target set was designed based on the West Nile 
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virus sequence (Kunjin strain) and was applied as a model for nucleic acid based viral 
recognition and detection on the proposed capacitive biosensor [38,39]. The process of DNA 
probe preparation for the biosensor has been optimized to include steps to minimize the effect of 
contaminants associated with commercial thiolated DNA probes. It is demonstrated here that this 
new biosensor produces an output of more than 70nF in capacitance change in response to as few 
as 20 complementary DNA targets (0.25 attogram) at a concentration of ~1.5 aM.  Due to the 
optimized cleaning process for the capacitive biosensor, including a pre-cleaning protocol, to 
improve covalent immobilization of purified single-stranded DNA probe oligomers onto the 
microelectrodes, the biosensor’s reproducibility was improved compared to the reported results.  
In addition to the low detection limit, the biosensor showed a good dynamic range of detection 
from 1 µL–1 to 105 µL–1 target molecules (20 to 2 million total targets), making it suitable for 
sample analysis in a typical clinical application environment. The capacitance results obtained in 
this study were verified using fluorescently labeled oligonucleotides on a fluorescence scanner. 
Capacitive affinity-based assays have long been considered highly sensitive [40], but low 
specificity and reproducibility [27] hinder further improvement in their sensitivity. The results 
presented in this paper provide a potential path for practical use of capacitive sensing technology 
for viral pathogen detection in clinical settings.  
4.2 Materials and Methods 
4.2.1. DNA Oligonucleotides and Reagents 
Validated HPLC purified DNA oligonucleotides were purchased from Integrated DNA 
Technologies (IDT, Inc., Coralville, IA). The sequences for single-strand DNA (ssDNA) oligonucleotides 
were based on the sequence of the West Nile Kunjin strain (Genbank Accession # AY274504) and were 
as follows:  




Complementary DNA target - 100% complementarity (Oligo 2): 
5’-AGGGATAGACACCAGTGCATACTA-3’ 
Noncomplementary DNA target (Oligo 3): 
5’-GCAATATAGATAACGCCAGATGGC-3’ 
Probe and target DNAs were resuspended in 1 TE-MgSO4 buffer (TE stands for Tris-HCI and 
EDTA), which contained 100 µM magnesium sulphate (MgSO4), 1 µM Tris-Hydrochloride (Tris-HCl) 
and 0.1 µM Ethylenediaminetetraacetic acid (EDTA), and were filtered through a 0.45 μm syringe filter 
(Millipore) prior to use. The 24-mer oligonucleotide DNA probe (Oligo1) was selected to form a stable 
duplex with its complementary target (Oligo 2) at room temperature, with minimal interference due to 
self-complementarity or secondary structure. The non-complementary target (Oligo 3) has 1 out of 24 
base pairs complementary with oligo1 (4.16% complementarity). 
For fluorescence detection, a second probe was generated that was 5'-thiolated (C6 propyl spacer) 
with a 3'-fluorescent Alexa Fluor 488 label (5'-ThioMC6-D/ 
TAGTATGCACTGGTGTCTATCCCT/AlexF488N/-3'), while complementary and non-complementary 
targets were 5'-labeled with fluorescent Alexa Fluor 594 dye (5'-Alex594N / 
AGGGATAGACACCAGTGCATACTA-3’ or 5’-Alex594N/GCAATATAGATAACGCCAGATGGC-
3'). The 11-Mercapto-1-undecanol (MCU) (97%; Sigma-Aldrich, St. Louis, MO) was dissolved in water 
and filtered through a 0.45 μm syringe filter (Millipore) prior to use. Potassium hydroxide (KOH) and 
hydrogen peroxide (H2O2, 30% w/w in H2O) (Sigma-Aldrich, St. Louis, MO) were used as received. 
Milli-Q water from Millipore (Billerica, MA) (18.2 MΩ·cm) was used in all experiments.  
4.2.2 Gold Interdigitated Microelectrodes Sensor 
Commercial gold coated IDE sensors were purchased from DropSens (Asturias, Spain). 
Each IDE has a finger width and spacing of 10 µm, with a total number of 125 fingers, a total 
electrode length of 6760 µm, and electrode surface area of 8.45 mm2. 
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4.2.3 Capacitance Measurement Setup  
Capacitance measurement data were collected using the Instek LCR-821 benchtop LCR 
meter (New Taipei City, Taiwan), which interfaces with a PC for data acquisition. A graphical 
user interface (GUI) on the PC was used for sending command signals to the LCR meter. Since 
the measurement is obtained from non-faradaic current, a 0 V DC bias voltage was applied 
across the IDE sensor. A 20 mV root mean square (RMS) AC voltage with 20 Hz frequency was 
applied to the IDE sensors. All capacitance readouts were recorded under 20 µL of 100 µM 
1 TE-MgSO4 buffer on the interdigitated electrodes and 50 data points were collected per 
reading. Capacitance data were analyzed using Matlab (Mathworks) and statistical tests were 
carried out with  (www.r-project.org). Only  < 0.05 values were considered as statistically 
significant.  
4.2.4 Melt Curve Generation for Buffer Optimization 
A CFX 96 Real Time system (C1000 Thermal cycler, Bio-Rad) was used to generate 
melt curves in order to follow DNA probe interactions with complementary and non-
complementary target oligos through double stranded DNA (dsDNA) formation under different 
buffer types and concentrations. For each case fluorescence emission was detected every 5 s 
from 4 °C to 95 °C at 0.5 °C degree increments. The duplex (dsDNA) formation reaction was 
carried out under different buffer conditions, specifically, in 1 M and 100 mM 1 TE-NaCl, and 
1 mM and 100 µM 1 TE-MgSO4. The DNA probe to DNA target ratio was fixed at 1:1 for 1 
µg/µL oligos for all reactions. SYBR Green nucleic acid gel stain (Life Technologies, Carlsbad, 
CA) was included in all reactions as a real time indicator of the presence of dsDNA.  
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4.2.5. Pretreatment of the Gold Electrodes Surface 
Upon exposure to ambient conditions the gold microelectrode surface is subject to a 
variety of uncontrolled conditions and contaminants, which can affect thiol reaction kinetics and 
therefore the probe attachment chemistry; because of this variability, a cleaning step is required 
immediately prior to functionalization. To prepare the surfaces, the chips with the gold 
microelectrodes were immersed in a solution of 50 mM KOH and 25% H2O2 for 10 min (Fischer 
et al., 2009), and thoroughly rinsed in Milli-Q water to remove the reagents, followed by oxygen 
plasma treatment. Baseline capacitance was recorded immediately following chemical cleaning 
and prior to plasma cleaning and probe immobilization.    
4.2.6. Pretreatment of Thiolated Single-Stranded DNA Oligomers 
In order for thiol bond formation between the oligo and the gold surface to proceed as 
expected, the 5’ thiol-modified oligomers require a reduction of the disulfide bonds prior to 
application. Immobilized TCEP Disulfide Reducing Gel (Thermo Fisher Scientific, Waltham, 
MA) was washed several times with 100 µM 1 TE-MgSO4 buffer prior to oligo addition in a 2:1 
TCEP gel: oligo ratio, and the mixture was incubated for 1 h on a rocker platform at 23oC. After 
incubation and a 1500 rpm spin for 2 min, the supernatant with reduced thiol-modified oligomers 
was transferred to a clean tube.  
4.2.7 SH-Modified DNA Probe Oligonucleotide Immobilization 
Gold IDE sensors were plasma-cleaned for 5 min in an O2 Plasma Etch PE-25 (Plasma 
Etch, Carson City, NV, USA) at a pressure of 200 mTorr and 150 W applied to the RF coil 
immediately before DNA probe incubation. The 10 µM ssDNA probe solution was prepared in 
100 µM 1 TE-MgSO4 buffer, and the gold microelectrodes were immersed overnight (15 to 17 
h) in 30 µL of the solution, then rinsed copiously with 100 µM 1 TE-MgSO4 buffer and Milli-Q 
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water, and dried with N2. The IDE sensors were then passivated with 20 µL MCU (5 µM in 
water) for 45 min to fill vacant gold sites and promote linear orientation of the ssDNA probe 
molecules. After MCU passivation, the electrodes were rinsed with water and dried with N2. All 
reactions were carried out at 23°C.  
4.2.8. DNA target hybridization  
The IDA sensors were immersed in 20 µL target DNA solutions for 30 min at room 
temperature, at target concentrations ranging from 1 µL–1 to 105 µL–1 in 100 µM 1 TE-MgSO4 
buffer. Following incubation, electrodes were copiously rinsed with 100 µM 1 TE-MgSO4 
buffer and dried with N2.  
4.2.9 Fluorescence scanning 
Gold IDA sensors were scanned using a FLUOstar Omega fluorescence scanner (BMG 
LABTECH, Cary, NC). Fluorescent Alexa Fluor 488 and Alexa Fluor 594 signals from the 
sensors were quantified and analyzed using the FLUOstar Omega software against experimental 
controls. The paired t-test was used for statistical analysis and only  < 0.05 values were 
considered to be statistically significant. 
4.3 Results and Discussion 
4.3.1 Measurement Setup 
The experiments carried out using the functionalized IDE sensors focus on quantifying 
the key sensor performance metrics of sensitivity and selectivity. To obtain these data, 
capacitance values of the IDE sensors were measured at four different stages of the sensing 
process: 
1. Cleaned bare gold electrode surfaces. The initial cleaning step was always applied to provide 
a baseline capacitance response.  
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2. Electrodes after covalent attachment of thiolated ssDNA probes. The layer of immobilized 
DNA probes has the intrinsic ability to capture complementary single-stranded target 
oligonucleotides. 
3. Electrodes after incubation with MCU. The measured capacitance at this stage is with the 
presence of buffer without any target DNA present in the buffer. The MCU is used to block 
any remaining unoccupied sites on the sensor surface and to align the probes perpendicular to 
the sensor surface in order to improve hybridization efficiency.  
4. Electrodes after incubation and hybridization with ssDNA targets, both complementary and 
non-complementary.  
Capacitance between IDE pairs was obtained by applying a 20 mV RMS AC voltage with 
a fixed frequency (stimulus) and by measuring the resulting current through the sensor IDE pair 
(response). The measurements of capacitance with the bare clean electrodes and with 
immobilized probes are mainly intended for verifying the state of probe immobilization. Unless 
otherwise stated, the change in capacitance after hybridization with either complementary or 
non-complementary targets is referred to as the difference between the capacitances before and 
after hybridization (i.e. capacitance difference between stage 3 and stage 4).   
Fig. 4.1A shows a schematic of the IDE sensor and Figs. 4.1B, C, D, and E show the 
equivalent circuits for stages 1, 2, 3, and 4, respectively. The quantity  is the intrinsic buffer 
solution resistance;  is an equivalent resistance representing a leakage current going through 
the electrode-electrolyte interface;  is the double layer capacitance created between the IDEs 
and adjacent buffer (Fig. 4.1B) resulting from the applied voltage; and  is the geometric 
capacitance which depends on the geometry of the electrodes and their configuration, which may 
be negligible relative to the double layer capacitance. The quantity  is the double layer 
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capacitance after probe immobilization, and is different from  because the ssDNA attachment 
modifies the surface capacitive characteristics of the electrodes. The additional double layer 
capacitance  results from incubation with MCU, and  is the double layer capacitance 





Figure 4.1 Equivalent circuit models on interdigitated electrode (IDE) sensors. (A) Bare 
IDEs with multiple fingers. (B) Equivalent circuit model for bare IDE sensors.  (C) Equivalent 
circuit model after probe immobilization. (D) Equivalent circuit model after MCU incubation 
and before target hybridization. (E) Equivalent circuit model after target hybridization for 
complementary targets.   
 
Because the MCU blocking agent acts as an insulation layer that pushes mobile ions 
away from the electrode into the solution, the total double layer capacitance is expected to 
decrease after the MCU step in stage 3. Similarly, after incubation and hybridization with the 
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complementary and non-complementary target DNA in stage 4, the resulting duplex structures 
should act to repel additional ions away from the electrode surface, resulting in further decreases 
in the double layer capacitance.  These behaviors are illustrated in Figs. 4.1C and D, where the 
sequential decreases in total double layer capacitance after the MCU and target incubation are 
denoted by  and  in a series configuration, and connected to the baseline double 
layer capacitance, . 
4.3.2 Effect of Buffer Composition and Temperature on Hybridization 
The specificity of an ssDNA probe is a critical factor that governs the performance 
characteristics of the biosensor, and which depends in part on electrolyte salt composition, 
concentration, and temperature. Two widely used salt buffers, each at two different ionic 
concentrations, 1 M and 100 mM 1 TE-NaCl, and 1 mM and 100 µM 1 TE-MgSO4, were 
tested to quantify their effect on the degree of hybridization between the probe and 
complementary and non-complementary targets. Intercalation of the planar SYBR Green 
fluorophore into dsDNA increases its fluorescence emission dramatically, allowing detection of 
dsDNA by monitoring fluorescence intensity. SYBR Green fluorescence intensity in RFU 
(Relative Fluorescence Unit) in the presence of 24-base synthetic probe and complementary/non-
complementary targets with increasing temperature is shown in Fig. 4.2A, illustrating double 
stranded DNA (dsDNA) formation due to DNA probe-target interactions in different buffer 
conditions and within 4–95°C temperature range. As temperature increases, dsDNA 
concentrations decrease resulting in decrease in SYBR green fluorescence intensity. To 
understand the effect of buffer composition on hybridization specificity, fluorescence intensity 
differences between complementary and non-complementary targets in each buffer type within 
the temperature range from 4°C to 95°C are shown in Fig. 4.2B. Non-complementary target RFU 
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background seen in the melt curve assay, especially at the lower temperature range (Fig 4.2A), 
can be attributed to two factors. First, lower temperatures favor non-complementary binding and 
specificity of duplex formation is increased with an increase in reaction temperature. Second, the 
conditions with very high target and probe oligo concentrations enhance the formation of primer 
dimers which contributed to higher SYBR Green signal at the beginning of the assay in the non-
complementary target samples. 
 
Figure 4.2 Effect of different buffers on DNA hybridization. (A) SYBR Green fluorescence 
in the presence of complementary (solid line) and non-complementary (dashed line) targets 
incubated with 24-base ssDNA probe in 1 M 1 TE-NaCl buffer (black), 100 mm 1 TE-NaCl 
buffer (red), 1mM 1 TE-MgSO4 buffer (blue) and 100 µM 1 TE-MgSO4  buffer (green) within 
temperature range from 4 ºC to 95 ºC.  (B) Corresponding relative fluorescence change between 
the complementary and non-complementary targets in four different buffers. The black dashed 
box indicates the temperature used in all the experiments. RFU = Relative fluorescence units. 
 
For three of the four buffers tested, the specificity increased with temperature up to 45°C 
with the trend reversing at temperatures above 45°C, except for the 100 µM 1 TE-MgSO4 
buffer.  The specificity from using the 100 µM 1 TE-MgSO4 buffer decreased with temperature 
up to 23°C, but it is still better than that for all other three salt buffers up to 45°C. For each salt 
type the specificity increased with decreasing ionic concentration, and this behavior is consistent 
with other results reported in the literature [41]. At the temperature used for all subsequent 
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hybridization studies (23°C) the 100 µM 1 TE-MgSO4 buffer demonstrates the best 
hybridization specificity. While low ionic concentrations are beneficial, in general, for achieving 
high specificity, a potential downside is that a low concentration of monovalent cations may 
hinder ssDNA probe immobilization on the IDE sensor surface [41]. The negatively charged 
DNA phosphate backbone, coupled with low cation concentration, may result in unacceptable 
electrostatic repulsion effects. However, the cation valence has a larger effect on probe 
immobilization than its concentration, so that bivalent cations, such as Mg2+, can mitigate the 
repulsion effect, and therefore result in a higher density of immobilized probes on the IDE sensor 
surface [41]. Furthermore, low ionic concentration serves to reduce measurement interference 
from the leakage current that often occur due to sodium deposits on the sensor surface. Overall, 
the 100 µM 1 TE-MgSO4 buffer was found to be the best compromise of composition and 
concentration to achieve high hybridization specificity without compromising ssDNA probe 
immobilization, and it was used as the electrolyte buffer for all remaining experiments.  
4.3.3 Optimization of Stimulus Signal Frequency  
The amount of change measured in double layer capacitance due to target binding is 
strongly dependent on the frequency of the stimulus AC signal. Since the double layer 
capacitance at the electrode-electrolyte interface is established due to the displacement of mobile 
ions in the fluid, it is expected that increasing the stimulus signal frequency will result in gradual 
disappearance of the double layer capacitance [37].  To gain a better understanding of the 
sensor’s response characteristics as a function of the stimulus signal frequency, a 20 mV RMS 
AC voltage is applied at three separate frequencies (20 Hz, 100 Hz and 1 kHz). Capacitance 
values for all four stages were measured for all three frequencies. The results shown in Fig. 4.3A 
verify changes in capacitance due to probe immobilization compared to the bare clean electrodes 
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(marked as “control” in Fig. 4.3A). The results in Fig. 4.3B illustrate that changes in capacitance 
before and after hybridization decrease with increase in operating frequency. To maximize 
sensor sensitivity, 20 Hz was used as the operating frequency for all remaining experiments. 
 
Figure 4.3 Frequency effects on capacitance during each step of sensor preparation/usage. 
(A) Changes in capacitance after probe immobilization at 20Hz, 100Hz, and 1 kHz frequencies. 
(B) Changes in capacitance after complementary and non-complementary (control) target 
hybridization at 20Hz, 100Hz, and 1 kHz frequencies. 
 
4.3.4 Immobilization of Oligonucleotides Probes on Sensor Surface 
A protocol for deposition of 5’ thiol modified ssDNA probe molecules onto the gold IDE 
surface and passivation of the IDE surface was established. ssDNA immobilization can be 
significantly affected by the condition of the IDE surface, the incubation time of 5’ thiol-
modified ssDNA with the gold surface, and the concentration of ssDNA. In general, the cleaner 
the IDE surface the better thiol-modified molecules will attach to the gold surface [42]. The IDE 
sensor surface was cleaned with the protocol described in Section 2.5 and treated with oxygen 
plasma to promote ssDNA immobilization. In addition to surface cleanliness, ssDNA 
immobilization is also determined by time the thiol modified ssDNA is in contact with the gold 
surface.  In general, twenty-four hour incubations are required to reach the saturation point for 1 
µM ssDNA immobilization in 1M salt conditions, and further exposure results in little additional 
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adsorption [43]. For ssDNA probe concentrations ranging from µM to mM, a surface density in 
the order of 103 cm–2 can be obtained after four hours of incubation [37]. In order to maximize 
sensor functionalization and the number of probes present on the functionalized sensor based on 
our previous work [19], overnight incubation was chosen for the 10 µM 5’ thiol-modified 
ssDNA probe in our experiments. Probe concentration was set in the µM range based on 
previous work on the gold electrode DNA biosensors [19] and was further optimized with 
additional chemical and plasma oxygen cleaning steps to maximize sensor coverage and target 
capture in 100 µM 1 TE-MgSO4 buffer. To validate 5’ thiol-modified ssDNA immobilization 
on the IDE sensor surface, capacitance measurements were obtained from 3 individual sensors 
after overnight ssDNA probe incubation, but before passivation with MCU. Fig. 4.4A 
demonstrates a statistically significant difference (p < 0.01) between the average capacitance 
measurements before and after probe immobilization, indicating that ssDNA probe was 
immobilized on the IDE surface. To further validate the capacitance results, AlexF488N labeled 
ssDNA probes were immobilized on IDEs as a complementary assay to monitor probe 
deposition. Total IDE fluorescence intensities were obtained before and after probe 
immobilization (Fig. 4.4(B)), showing that incubation with fluorescent ssDNA probe resulted in 
a significant increase in fluorescence on the IDE (p < 0.01) similar to what was observed by 




Figure 4.4  Validation of probe immobilization on IDE sensors. (A) Capacitance 
measurements before and after probe immobilization. (B) The fluorescence intensity before and 
after probe immobilization.  ** paired t-test: p < 0.01. 
 
4.3.5 Specificity  
After probe immobilization and MCU incubation, specificity tests of complementary and 
non-complementary DNA targets were conducted. The rate of DNA hybridization is dependent 
on DNA length, with shorter duplex regions showing higher hybridization rates [38,44]. Based 
on the 24-base DNA target used in the experiments, target incubation was set for 30 minutes at 
room temperature (23°C). AlexF594N labeled complementary and non-complementary targets 
with the concentration of 105 µL–1 in 20 µL of 100 µM 1 TE-MgSO4  buffer were incubated 
with the probe immobilized IDE surface, and excess target DNA was washed off. The average 
capacitance of sensors incubated with complementary and non-complementary target DNAs with 
the standard error of three individual sensors are shown in Fig. 4.5A. Non-complementary target 
DNAs did not induce a significant capacitance change, whereas complementary DNA induced a 
large capacitance change in the sensor. This is further validated using fluorescent target capture 
on the sensor surface (Fig. 4.5B). Decreased capacitance on IDE surfaces upon target binding 
has been previously reported in the literature. When ssDNA probes are immobilized on the IDE 
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surfaces, the double layer of ions due to the polarized metal surface are displaced [45]. When 
complementary DNA strands bind with the probes, the distance between the charge on the 
surface of the electrode and the ions in the electrolyte increases, resulting in decreasing in the 
overall capacitance [27,37].  
 
Figure 4.5 Specificity of target hybridization. (A) Capacitance measurements before and after 
complementary and non-complementary target hybridization. (B) Fluorescence intensity before 
and after complementary and non-complementary target hybridization. ** paired t-test: p < 0.01; 
* paired t-test: p < 0.05. 
 
4.3.6 Sensitivity 
 To determine the sensitivity of the sensor, DNA concentrations between 0 to 2 million 
molecules, consistent with the range seen in typical clinical settings, were incubated on the 
sensor and capacitance was determined (Fig. 4.6). Complementary target DNAs displayed a 
significant capacitance change as few as 20 DNA molecules, whereas non-complementary DNAs 
did not significantly change capacitance even at 2 106 molecules.  For target concentrations 
between 20 and 2 million DNA molecules, complimentary targets showed a linear response in 
capacitance change with increasing target concentration, indicating an excellent correlation 
between low-range target concentrations and capacitance responses.  These results demonstrate 
that the label-free capacitive detection limit for the complementary targets is at least as low as 20 
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DNA molecules (~1.5 aM). Increasing complementary target concentrations increased 
capacitance changes, whereas increasing non-complementary DNA concentrations did not 
significantly increase capacitance. There have been a number of ultra-high sensitive biosensors 
reported to date which achieved limits of detection similar to the results presented in this paper. 
Most of these ultra-high sensitive approaches relied on novel amplification methods using nano-
materials, such as nano-particles [46] and quantum dots [47]. Other approaches using nano-
structures include the use of a novel molecular gate structure with carbon-nanotubes to control 
sensor’s conduction state [48], the use of carbon nanotubes (CNTs) as a highly conductive agent 
to enhance redox current sensitivity [49], and the use of CNTs combined with Au nano-particles 
to increase sensor surface area [50]. However, these approaches incur additional costs related to 
additional sample preparation for nano-materials and amplication, and nano-scale device 
manufacturing. The biosensor presented in this paper achieved a high sensitivity comparable to 
those achieved using nano-materials for amplification and other enhancements, thus lowering the 
cost and simplifying sample processing and device manufacturing requirements. 
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Figure 4.6 Capacitance response from 0 to 2x106 complementary (red line) and non-
complementary (black line) DNA targets.  
 
4.4 Conclusion 
In this paper, a capacitive biosensor with high sensitivity and a wide dynamic detection 
range is presented. The carefully designed protocol for sensor surface preparation, probe 
immobilization, and hybridization strikes a balance among the competing factors of ease of 
immobilization, specificity, and the overall capacitance measurement quality. The reported 
biosensor improves the state of the art on three fronts. First, the sensor was able to produce an 
output of more than 70nF in capacitance change in response to as few as 20 complementary 
DNA targets (0.25 attogram) at a concentration of ~1.5 aM. The magnitude of capacitance 
change increases linearly with complementary target concentration in the range between 20 and 
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2 million target DNA molecules. The detection limit of this biosensor is among the lowest 
reported to date for a non-faradaic capacitive biosensor. Second, sensor specificity is clearly 
demonstrated by the capacitance change differential between complementary and non-
complementary target binding. For non-complementary ssDNA target molecules, the measured 
change in capacitance is significantly less than that for the complementary ssDNA target and 
does not display an appreciable change in capacitance with non-complementary molecule 
concentration increases. Third, the sensor achieved a dynamic range for detection between 1 µL-1 
and 106 µL-1 target molecules (20 to 2 million target DNA molecules) with excellent linearity in 
the measurement of capacitance changes. Combining its performance in sensitivity, specificity, 
and dynamic detection range, this capacitive biosensor demonstrates the potential to be a viable 
technology for low-cost, low-power, ease of use, and rapid detection technology that is a critical 
step toward POC pathogen detection. Areas where further investigations can provide more 
optimized conditions for the capacitive biosensor include optimized incubation time to decrease 
time for sample analysis. Furthermore, future development of this capacitive biosensor includes 
detection of viral nucleic acids (DNA and RNA) from complex biological samples, as well as 
platform multiplexing, with the ultimate goal of developing a POC device for rapid and 
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CHAPTER 5: AN ULTRA-SENSITIVE CAPACITIVE MICROWIRE SENSOR FOR 




Detecting and analyzing the humoral antibody response in clinical samples is critical for 
diagnosis of infectious disease, understanding pathogenesis and immune response kinetics, and 
vaccine development [1]. Current methods for antibody detection include immunoprecipitation 
(e.g., hemagglutination), immunoblotting, plaque reduction neutralization tests, and 
immunosorbent assays [2]. Among these methods, the enzyme-linked immunosorbent assay 
(ELISA) is used as the gold standard clinical diagnostic tool for antibody detection [3]. However, 
established detection techniques, including ELISAs, require large instrumentation in centralized 
laboratories and specialized training to execute and interpret the results [4,5]. These 
disadvantages limit the use of ELISAs in low-resource settings [4,6]. When standard laboratory 
tools are not locally accessible, samples must be collected, stored under specific conditions, and 
sent to reference laboratories, which leads to additional turnaround time. As a result, many cases 
go undiagnosed and this indicates an urgent need for sensitive and robust assays that can be used 
at the point of care (POC) to quickly diagnose infection and provide health-care providers with 
actionable information. 
As one branch of electrochemical immunosensors, capacitive biosensors employ direct 
sample application for label-free detection. Other electrochemical antibody sensors have been 
developed for serological analysis, but these designs incorporate enzymatic labels [7,8] or toxic 
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redox couples [9] that increase the complexity and cost of the sensor.  Compared to other 
immunosensors, capacitive biosensors are ideal candidates for sensitive and label-free 
bioanalysis platforms.  Capacitive sensing is based on the underlying theory of the electrical 
double layer [10,11], where the working electrode is conjugated with probe that binds its 
respective target to increase the thickness of the double layer.  This increase in double layer 
width produces a corresponding change in capacitance [12,13]. Such capacitive signals provide a 
direct measure of target binding and can be rapidly detected. Based on our previous work using 
capacitive change to detect DNA [12], the sensitivity of capacitive biosensors is far superior to 
traditional diagnostic assays [12–15] and is ideal for the detection of low antibody titers found 
during early stages of infection. Capacitive biosensors are thus an attractive sensing modality 
that has not yet been fully explored for specific antibody detection. 
The goal of this work is to develop a novel POC platform that can specifically detect low 
levels of antigen-specific antibodies in serum. Due to its clinical relevance, Zika virus (ZIKV) 
was chosen as a model system to validate the sensing platform. ZIKV is an emerging Flavivirus 
that is closely related to other mosquito-borne viruses of clinical importance, such as Yellow 
Fever, West Nile, and dengue viruses. It has become a major public health concern due to 
neurological complications in infected adults [16–19] or severe developmental complications for 
fetuses of infected women [20–24]. Therefore, accurate and early diagnosis of ZIKV infection is 
essential for proper monitoring and medical intervention in these cases.  
In this study, we developed a capacitive immunosensor that specifically detects ZIKV 
and Chikungunya (CHIKV) antibodies by the recognition of their respective envelope (E) 
protein. The sensor presented here directly measures ZIKV-specific monoclonal antibody, with a 
lower detection limit of approximately 10 antibody molecules in a 30 µL sample. The antibody 
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detection system discriminates between virus specific antibodies with little cross-reactivity, 
indicating a high degree of selectivity, and can even differentiate antibody isotypes. We also 
demonstrate that our system can specifically and sensitively detect polyclonal anti-ZIKV 
antibodies present in mouse serum. This method is distinguished from previous antibody 
detection methods not only in the platform, but also by its superior sensitivity and specificity.  
5.2 Experimental section 
5.2.1 Study design 
The purpose of this study was to build a sensitive capacitive biosensor for the specific 
detection of ZIKV antibody.  The working microwire surface was functionalized with E protein 
from either ZIKV (ZIKV E) or Chikungunya virus (CHIKV E). Detection limits for the device 
were first determined with monoclonal antibody samples. Anti-ZIKV E antibody was employed 
as a specific target while anti-CHIKV E, anti-Dengue, and anti-M13 were used as nonspecific 
targets. The microwire biosensor was also used to isotype the monoclonal antibodies with anti-
mouse IgG1, IgG2a, IgG2b, IgG3, IgA and IgM antibodies. The microwire sensor was then 
validated using pre-immune and immune mouse serum collected 4, 7, 14 and 21 days post ZIKV 
immunization. Next, the sensor was used to isotype Day 4 and 21 mouse sera for IgM and IgG 
antibody. 
Information for development of DNA vaccine vectors, immunization protocol, serum 
collection, Western blots and ELISAs confirming antibodies in serum are described in 
Supplemental Information.  Representative serum samples positive for ZIKV IgG antibody by 
Western blot were included in the serum testing. Three experimental replicates were performed 
for each monoclonal antibody and serum sample. Control samples and experimental sample 
replicates are indicated in the text and figure legends.  
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5.2.2 Materials and equipment 
Potassium hydroxide (KOH), iron (III) chloride hexahydrate (FeCl3∙6H2O), 30% 
hydrogen peroxide (H2O2), and absolute ethanol were purchased from Fisher Scientific 
(Fairlawn, NJ). High-purity silver ink was purchased from SPI Supplies (West Chester, PA). 11-
Mercaptoundecanoic acid (MUA) was purchased from Santa Cruz Biotechnology (Dallas, TX). 
3-Mercapto-1-propanol (MPOH) was purchased from Tokyo Chemical Industry Co., Ltd. 
(Portland, OR). N-Hydroxysuccinimide (NHS) and 1-Ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC) were purchased from Acros Organics (Geel, Belgium). Ethanolamine, 
Tween-20, and 2-(N-morpholino) ethanesulfonic acid (MES) was purchased from Sigma-Aldrich 
(St. Louis, MO). Phosphate buffered saline (1  PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4 and 1.8 mM KH2PO4, pH 7.4) was purchased from Hyclone (Logan, UT). All reagents 
were used as received without further purification. All stock solutions were prepared using 
ultrapure water (18 MΩ cm) purified with the Nanopure System (Kirkland, WA). 99.99% pure 
gold (25 µm) and silver (25 µm) wires were purchased from California Fine Wire Company 
(Grover Beach, CA) and used as the working and reference electrode materials, respectively. 
Recombinant ZIKV E, recombinant CHIKV E, and mouse monoclonal anti-CHIKV E 
antibodies were purchased from MyBioSource, Inc. (San Diego, CA) and stored at –20°C until 
use.  M13 antibody (Abcam ab24229), anti-dengue 2 envelope antibodies (Abcam ab80914), and 
ZV-2 Anti-Zika envelope antibody [25]  were generously provided by Dr. Michael Diamond.  
ZIKV immune mouse serum was generated after DNA immunization of mice with ZIKV virus-
like particle expression plasmids modeled from previous work [26].  Details for the construction 
of the immunization plasmids, immunization, serum collection, and initial antibody testing of 
serum can be found in Supplemental information. Anti-Mouse IgG1, IgG2a, IgG2b, IgG3, IgG, 
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IgA and IgM antibodies were purchased from BD Biosciences (San Jose, CA), and stored at 4°C 
until use.  
5.2.3 Working electrode surface functionalization  
The 25 µm diameter Au microwire was used as the working electrode. To prepare the 
surface of the electrodes, the Au microwire was immersed in a 20 mL solution of 50 mM KOH 
and 25% H2O2 for 10 min [27], and thoroughly rinsed in Milli-Q water to remove residual 
reagent. The Au microwire was then plasma cleaned for 2 min in an O2 Plasma Etch PE-25 
(Plasma Etch, Carson City, NV, USA) at a pressure of 200 mTorr and with 150 W applied to the 
RF coil. An alkanethiol self-assembling monolayer (SAM) layer formation reaction was 
performed immediately after plasma cleaning. A 10 mM mixed solution consisting of a 1:1 ratio 
of 3-MPOH (3-Mercapto-1-propanol) to 11-MUA (11-Mercaptoundecanoic acid) was prepared 
in the absolute ethanol. The gold microwires were immersed in the mixed solution for 48 hours 
without light at room temperature and then rinsed three times with deionized water to remove 
residual reagent.  
The MUA carboxyl groups on the SAM were immediately activated for antigen coupling 
by a two-step NHS/EDC bioconjugation protocol. The SAM modified gold microwires were 
incubated in 20 mL of 20 mM EDC and NHS in 0.1 M MES (2-(N-morpholino) ethanesulfonic 
acid) (pH 6.0) buffer for 30 minutes and then rinsed with 20 mL 0.1 M MES buffer.  A solution 
of 8 µg/mL antigen (ZIKV E or CHIKV E) was incubated on the activated MUA surface for 2 
hours. After antigen incubation, the surface was incubated in 0.1 M ethanolamine in 1  PBS 
solution for 30 min to passivate unbound, activated MUA. The wire was rinsed with 1  PBS, 




5.2.4 Microwire chip fabrication 
The capacitive sensor was constructed using a glass substrate with a 
polydimethylsiloxane (PDMS) layer 1 mm in height, and two metal microwires. Liquid sample 
confinement was achieved by making a 6 mm diameter hole in the hydrophobic PDMS that was 
bonded on a hydrophilic glass slide. To make the PDMS layer, PDMS prepolymer [RTV 615 A 
and B (10:1, w/w)] was mixed, degassed, then poured onto a flat silicon wafer to yield a 1 mm-
thick fluidic layer [28]. The PDMS layer was baked for 30 min at 80°C, then peeled from the 
silicon wafer. A biopsy punch (Technical Innovations, FL, Inc. USA) was used to create 6 mm 
diameter wells for sample containment.  Both the PDMS and glass were exposed to oxygen 
plasma (Plasma Etch, NV, USA) for 1 min, then contacted to form a permanent bond. On the 
PDMS with a 6-mm diameter well, Ag/AgCl and Au microwires were spaced 1 mm apart across 
the well. A two-electrode system was employed using Au and Ag/AgCl microwires as the 
working and reference electrodes, respectively, each with a surface area of 4.7 10–3 cm2. 
Ag/AgCl reference electrodes were made by dipping silver Ag wire in 50 mM iron (III) chloride 
for 50 s, forming a silver chloride layer on the surface. Silver paint was applied to wire ends to 
create touchpads that could be connected to the capacitance reader. 
5.2.5 Capacitance measurement device and setup 
Capacitance measurement data were collected using an Instek LCR-821 benchtop LCR 
meter (New Taipei City, Taiwan) with a PC interface for data acquisition.  Because double layer 
capacitance is a non-faradaic signal, a 0 V DC bias voltage was applied. A 20 mV root mean 
square (RMS) AC voltage was applied to the sensors at frequencies of 20 Hz. All capacitance 
readouts were recorded in parallel mode in 30 µL of 0.1  PBST and 60 data points were 
collected per reading. A faradic cage was used to remove electrical interference during readout. 
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Capacitance data was analyzed using Matlab (Mathworks) and statistical tests were performed 
using R (www.r-project.org). Only p values less than 0.05 were considered statistically 
significant. 
5.2.6 Monoclonal antibody detection and antibody isotype detection  
For antibody detection, 30 µL dilution of monoclonal antibody was added to the micro-
well and incubated for 5 min at room temperature in 1  PBST buffer containing 1 to 103 
molecules of each monoclonal antibody. Following incubation, electrodes were rinsed three 
times with 1  PBST buffer and three times with 0.1  PBST buffer. 
For antibody isotype determination, a 30 µL monoclonal CHIKV E antibody was added 
to the micro-well and incubated for 5 min at room temperature in 1  PBST buffer.  Electrodes 
were rinsed with 1  and 0.1 PBST, and then antibodies specific for each isotype were added to 
the well with dilutions of 1 to 103 anti-isotype antibody molecules in 1  PBST buffer. Following 
incubation, electrodes were rinsed again three times with 30 µL 1  PBST buffer and three times 
with 30 µL 0.1  PBST buffer. Capacitance measurements were then performed as described in 
the Capacitance Measurement and Device Setup section. 
5.2.7 Mouse serum sample antibody detection and antibody isotype detection  
Clarified mouse sera were diluted 1:106 and 1:1012 in 30 µL 1  PBST buffer, and 
incubated on microwire chips for 5 min at room temperature.  Following incubation, electrodes 
were rinsed three times with 30 µL 1  PBST buffer and three times with 30 µL 0.1  PBST 
buffer.  To determine the isotype of anti-ZIKV antibodies in the mouse sera the microwire sensor 
was first immersed in 30 µL of mouse serum diluted 1:106 in 1  PBST for 5 min at room 
temperature. Antibodies specific for each isotype were then incubated for 5 min at dilutions of 
1:106 and 1:1012 in 30 µL 1  PBST buffer. Following incubation, electrodes were rinsed three 
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times with 30 µL 1  PBST buffer and three times with 0.1  PBST buffer prior to capacitance 
reading. 
5.3 Results and discussion 
5.3.1 Sensor design and working principles 
The label-free capacitive immunosensor introduced here uses microwire electrodes for 
sensitive and rapid detection of antibodies produced during the host immune response to 
infection, in this case antibodies against ZIKV. The device is made of low-cost, easily acquired 
materials. A glass slide is used as the base substrate with a biocompatible polydimethylsiloxane 
(PDMS) well for sample application.  Au and Ag/AgCl microwires (working and reference 
electrodes respectively) are immobilized across the PDMS well (Figure 5.1a) and 30 µL of liquid 
sample is added to the well and incubated for 5 min. Measurements can then be taken in as 
quickly as one minute. Microelectrode wires, compared to other electrode fabrication methods 
like ink printing, paste, and sputter-coated electrodes, demonstrate increased mass transport rates 
due to radial diffusion [29]. This increases the current density and consequently improves 
sensitivity and enhances detection limits [30]. In addition, microelectrodes hold additional 
benefits of simple fabrication without expensive equipment, ease of surface chemical 
modification, and availability in different pure and alloyed compositions [31].  
The capacitance at the electrode/solution interface in our system can be modeled as 
several capacitors in series, as visualized in Figure. 5.1b. The first component constitutes the 
insulating SAM layer on the electrode surface, . The second, , includes the anchoring 
groups and the recognition element (antigen), which is followed by the concentration-dependent 
antibody layer, . Based on this model, the specific binding of antibody to antigen results in a 
change in the total capacitance, .  is generally large and constant and its contribution to 
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the  may therefore be ignored. The sensitivity of the sensor is predominately determined by 
the relative capacitance between antigen and antibody. In this case, use of a large analyte like 
antibody increases the sensitivity of our sensor by creating a proportionally larger increase in 
double layer width compared to smaller analytes like antigens [32] . This ultra-sensitivity is 
necessary to adapt the immunosensor for pre-symptomatic pathogen detection, which is currently 
only achieved by nucleic acid testing (NAT) [33]. 
 
Figure 5.1 Schematic of capacitive immunosensor design and working principles. (a) The 
device layers and resulting immunosensor shown from the top. RE: reference electrode, WE: 
working electrode; (b) Working electrode (Au microwire) surface chemistry and functionalized 




5.3.2 Specificity tests and detection limit with monoclonal antibodies 
To characterize the performance of the capacitive immunosensor, the microwire sensor 
immobilized with ZIKV E (probe) was first tested with monoclonal antibodies diluted in 1  
PBST buffer (pH 7.4, 0.05% Tween 20). Anti-ZIKV E (experimental sample), anti-M13 
antibody (control sample), anti-CHIKV E (control sample), and anti-DENV antibody (control 
sample) were tested (Figure 5.2a). Each antibody was applied to the sensor at concentrations 
ranging from 1 to 103 molecules per 30 µL. The mean negative capacitance changes, 
, (where BL = baseline) for each antibody sample with standard deviations 
(n = 3) are presented in Figure 5.2b. The  obtained from anti-ZIKV E is proportional to the 
concentration/number of antibodies in the experimental sample and can be fit with linear 
regression as shown in the Figure 5.2b (R2 = 0.9813). These results demonstrate that the 
magnitude of the capacitance change for the sensor is proportional to the concentration of the 
specific target bound. In comparison, the  from control samples have no significant change 
at any concentration tested, suggesting that there was no significant binding between ZIKV E 
and control antibodies. In addition, it is notable that the  obtained from anti-ZIKV E 
antibody sample containing 10 molecules is statistically significantly different from the control 
antibody samples, indicating that the present detection platform has a detection limit as low as 10 
antibody molecules/30 µL, far superior to that of other immunosensors or ELISA assays [14].  
To demonstrate that the device can be adapted to other antigen/antibody pairs, the sensor was 
functionalized with CHIKV E2 antigen and tested with the same four monoclonal antibodies at 
the same concentration ranges (Figure 5.2c).  As expected, the  obtained from anti-CHIKV 
E antibody is proportional to the concentration/number of corresponding anti-CHIKV E antibody 
and is fitted via linear regression shown in the Figure 5.2d (R2 = 0.9466). The other three 
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nonspecific antibodies did not induce significant responses. Again, the  obtained from anti-
CHIKV E antibody sample containing 10 molecules is statistically significantly different from 
the three non-specific antibodies, which confirms a detection limit of 10 antibody molecules/30 
µL.   
Collectively, these results show that the immunosensor functionalized with specific 
antigen can selectively capture antigen-specific antibodies at extremely low concentrations 
without nonspecific binding from other tested antibodies.  This suggests an excellent 





Figure 5.2 Specificity tests with monoclonal antibodies. a) Illustration of ZIKV E antigen as 
the recognition element to test one specific and three nonspecific antibodies; (b) Capacitance 
responses for the four antibodies at concentrations from 0 to 103 molecules per 30 µL in 1  
PBST buffer (n = 3 at each concentration, mean ± STD). The linear fit for specific anti-ZIKV E 
is shown in the plot as a dashed line; (c) Illustration of CHIKV E antigen as the recognition 
element to test one specific and three nonspecific antibodies; (d) Capacitance responses for four 
antibodies at concentrations from 0 to 103 molecules per 30 µL in 1  PBST buffer (n = 3 at each 




5.3.3 Isotyping tests with monoclonal antibodies 
The isotype of antigen-specific antibodies is commonly determined to elucidate the stage 
of an infection, with IgM antibodies being present early in infection and IgG antibodies present 
later in infection. To explore if our platform can be used to determine antibody isotypes, the 
microwires were functionalized with CHIKV E antigen probe and subsequently saturated with 
corresponding IgG 2b antibody against CHIKV E (103 molecule/ 30 µL). The capacitance value 
for anti-CHIKV antibody was set as a new baseline ( ).  The devices were then incubated with 
six secondary antibodies with different anti-mouse antibody specificities (IgG1, IgG2a, IgG2b, 
IgG3, IgA and IgM) at concentrations ranging from 1 to 103 molecules per 30 µL (Figure 5.3a). 
Figure 5.3b presents the mean negative capacitance changes,  for 
each antibody sample with standard deviations (n = 3). As predicted by the circuit model, an 
additional capacitance change was observed from specific anti-IgG2b antibody samples in all the 
concentrations applied. In addition, the  of anti-IgG2b antibody increases proportionally 
with increasing concentrations of anti-IgG2b antibodies. In contrast, the five nonspecific anti-
isotype antibodies did not increase capacitance responses (Figure 5.3b). Supporting previous 
results of the detection limit, the capacitance of 10 anti-IgG 2b antibody molecules/30 µL is 
statistically significantly different from the nonspecific antibodies. These results indicate that our 





Figure 5.3 Isotyping tests with monoclonal antibodies. (a) Illustration of CHIKV E antigen-
antibody complex to determine the isotype of anti-CHIKV E (IgG 2b). Six secondary antibodies 
are used here to perform the test: anti-IgG1, anti-IgG2a, anti-IgG2b, anti-IgG3, anti-IgA and 
anti-IgM; (b) Capacitance responses of the isotype tests with six secondary antibodies at 
concentrations from 0 to 103 molecules per 30 µL in 1  PBST buffer (n = 3 at each 
concentration, mean ± STD).  A linear fit is shown in the plot for secondary IgG2b antibody. 
 
5.3.4 Detection of anti-ZIKV antibodies during an immunization time-course 
To explore the performance of the capacitive immunosensor in a complex matrix with 
various interfering species, we tested if ZIKV-specific polyclonal antibodies could be detected in 
mouse serum.  Ten CD1 mice were administered with a DNA vaccine for ZIKV and serum 
samples were collected before vaccination (pre-immune samples), and 4, 7, 14 and 21 days after 
vaccination. To confirm a Day 21 anti-ZIKV immune response, the samples were first tested for 
IgG antibody using strip Western blots and ZIKV-infected Vero cell lysates as the antigen (Fig. 
S5.1).  Of the 10 vaccinated mice, two with strong anti-Zika IgG antibody responses (mice 3 and 
4) and one with a weak anti-Zika IgG antibody response (mouse 6) were chosen for further 
analysis.  Mouse 3, 4, and 6 samples were tested with the ZIKV E functionalized sensor. To 
determine suitable dilutions of the mouse serum samples for the platform, the pre-immune and 
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Day 4 mouse sera were tested with a wide range of concentrations (1:1018 to 1:103 dilutions in 
1  PBST). As shown in Fig S5.2, the average  obtained from the Day 4 serum increases 
along with increased concentration and the pre-immune sera conversely shows no significant 
change in the average  across the dilution range. There is no significant difference between 
pre-immune and Day 4 serum at dilutions lower than 1:1012.  All dilutions at and above 1:1012 
show statistically significant differences with p-values less than 0.05 (Fig S5.2).  These results 
indicate that this platform can differentiate vaccinated from non-vaccinated mouse serum at 
ultra-dilute concentrations as low as 1:1012 and as few as four days after vaccination, which is 
comparable to the early acute phase of infection before or concurrent with disease 
symptomology [34]. Subsequently, this assay can extend the window of antibody detection into 
the early acute phase of infection.  
Based on the results in Fig S5.2, two dilutions of the mouse serum, 1:106 and 1:1012 were 
chosen for detection for Day 4, 7, 14 and 21 mouse serum samples. Each of the three biological 
replicates was tested and averaged. Every biological replicate is the average of three technical 
replicates. The  for each post-vaccination sample was compared to the pre-immune sample 
as shown in Figure 5.4a and Figure 5.4b. At a 1:1012 dilution, the  increases with each time 
point after vaccination, and saturates around Day 14. The lower  for Day 14 can be 
attributed to its smaller sample size as there was no serum collected for mouse 6 on this day. 
Although results are similar for the 1:106 dilution compared to the 1:1012 dilution, it is notable 
that the  for this dilution saturates as early as Day 4 after immunization. Because the 1:106 
dilution is significantly more concentrated, this is not unexpected. More importantly, this 
capacitive immunosensor can detect target antibodies at extremely low concentrations as early as 




Figure 5.4 Immune response kinetics for mouse serum samples. Capacitive response to 
mouse serum at different time points pre- and-post vaccination with ZIKV. (a) The mouse serum 
was tested at a 1:1012 dilution in 1  PBST buffer; (b) The mouse serum was tested at a 1:106 
dilution in 1  PBST buffer. Three biological samples (n = 3, mean ± STD) for each time point 
were tested except for Day 14 (n = 2, mean ± STD). Each biological sample shown is the average 
of three technique replicates. The paired t-test was carried out between pre- and post- vaccination 
with ZIKV samples. * paired t-test: p < 0.05.  
 
Reliably detecting as few as ten molecules and accurately analyzing serum at dilutions of 
1:1012, these results suggest that our sensor has a sensitivity that is far superior to other platforms 
125 
 
[9,35]. This increased sensitivity enables us to detect an antibody response four days earlier 
compared to established serological methods [36]. Our sensor also requires less sample volume 
than comparable ELISAs (30 µL of 1:1012 vs 50-100 µL of 1:400 diluted sample [37]), which 
preserves precious serum sample and reduces reagent waste. Furthermore, whereas the CDC 
ZIKV MAC-ELISA needs 12+ hours to obtain results from sample application, our sensor can 
produce results in under ten minutes. This could result in faster diagnostics needed to determine 
a timely and effective therapeutic intervention. 
5.3.5 Specificity tests with mouse sera 
To further characterize the specificity of our sensors, we examined whether anti-ZIKV 
serum had any cross-reactivity with CHIKV sensors.  CHIKV E antigen was conjugated to the 
microwire as a control probe to test two dilutions (1:1012 and 1:106) of the pre-immune and 
ZIKV-vaccinated Day 21 mouse serum. Figure 5.5 compares the  results obtained with 
specific ZIKV E probe and control CHIKV E probe. The y-axis marks the difference in  
between Day 21 and pre-immune samples, and the x-axis denotes the two probes used. As shown 
in Figure 5.5a, the  between Day 21 and pre-immune mouse serum using ZIKV E probe is 
approximately 9 nF at the 1:1012 dilution, suggesting that ZIKV antibody concentrations increase 
significantly after 21 days post vaccination. In comparison, the CHIKV E sensor shows almost 
no change (~0 nF), 21 days post ZIKV vaccination, indicating that only specific binding 
occurred.  A small increase in capacitance may be attributed to small amounts of nonspecific 
adsorption. There is a statistically significant difference between the ZIKV E and CHIKV E 




Figure 5.5 Specificity tests with mouse serum samples. (a) The difference between the 
negative capacitance change for Day 21 and pre-immune mouse serum samples at a 1:1012 
dilution in 1  PBST buffer are compared for ZIKV E and CHIKV E recognition antigens (n = 3 
at each concentration, mean ± STD).  (b) The difference between the negative capacitance for 
Day 21 and pre-immune mouse serum samples at a 1:106 dilution in 1  PBST buffer are 
compared for ZIKV E and CHIKV E recognition antigens (n = 3 at each concentration, mean ± 
STD). ** paired t-test: p < 0.01. 
 
These results demonstrate satisfactory reproducibility and further validate the excellent 
specificity and sensitivity of this platform in a complex physiological matrix.  Therefore, our 
sensor may be useful for direct detection of antigen-specific antibodies in serum and other 
potential types of biological sample.  
5.3.6 Isotyping of antibodies in mouse serum samples 
Isotyping is a diagnostic component required to separate acute from past infections. To 
characterize whether our wire sensor platform can be used to for isotype determination of a 
serum sample, wire sensors were functionalized with ZIKV E protein and saturated with 
antibody using a 1:106 dilution of serum from Day 4 or Day 21.  Anti-mouse IgM or IgG was 
applied to the sensor and the results are compared in Figure 6.  As expected from published 
flavivirus antibody kinetics [38] and the corresponding ELISA data (Fig S5.3), Day 4 IgM levels 
were higher than IgG.  It was somewhat surprising that the sensor detected constant levels of 
IgM between Day 4 and Day 21 given that the ELISA showed an increase from Day 4 to Day 21.  
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This may be explained by saturation of the sensor.  A recent report, however, indicates that anti-
ZIKV IgM levels drop off 8-16 days after symptom onset [36].  The discrepancy between our 
ELISA data and theirs may be due to our use of the immunodominant E protein instead of NS1 
as antigen or it could be related to differences in host species. Antibody kinetics for dengue virus 
indicate that IgM can be detected for over 90 days [38], suggesting that a higher titer for Day 21 
is reasonable.  The sensor results also show an increase in IgG levels from Day 4 to Day 21, 
which agrees with the ELISA data.  However, higher IgG than IgM levels do conflict somewhat 
with the ELISA results, which show slightly higher IgM for both days.  Because the IgM is 
significantly larger than IgG, it is possible that steric hindrance causes the IgM sensor to saturate 
faster than the IgG sensor.  As a smaller molecule, more IgG may be able to bind to the wire 
surface and produce a larger signal. 
 
Figure 5.6 Isotyping of antibodies in mouse serum samples. Capacitive response of antibody 
isotypes in mouse serum at day 4 and 21 with ZIKV. The mouse serum was tested at a 1:106 
dilution in 1  PBST buffer. Three biological samples (n = 3, mean ± STD) for each time point 
were tested. Each biological sample shown is the average of three technical replicates.  
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Cabral-Miranda et al. recently published an immunosensor for ZIKV antibody with isotyping 
capacity that was able to detect a 106 to 107 dilutions of serum [9]. However, the reported design 
incorporates a toxic redox couple that limits its point of care use in addition to decreased 
sensitivity compared to our system.  Without using labels or redox couples, our sensor can 
distinguish antibody isotypes from a complex serum matrix containing a mixture of isotypes.  
These results enhance the applicability of the sensor for point of care diagnostic purposes and 
even for research purposes.  
5.4 Conclusion 
Although diagnosis of infectious diseases like ZIKV require laboratory confirmation, 
current methodologies are limited to use by specialized diagnostic laboratories. Recent outbreaks 
like that of Ebola virus and ZIKV indicate a growing need for simple, sensitive, and selective 
diagnostics amenable to a point of care setting. The ultra-sensitive capacitance sensor introduced 
in this study represents a simple and robust platform for pathogen-specific antibody detection in 
serum. Within minutes, it can detect as few as 10 antibody molecules in a 30 µL volume, as well 
as determine the antibody isotype. Without using labels or redox couples, our sensor can detect 
anti-ZIKV antibodies during an immunization time course and distinguish antibody isotypes 
from a complex serum matrix containing a mixture of isotypes.  Furthermore, this sensor design 
can be easily integrated with microfluidics and handheld measuring devices to make it suitable 
for field work and point of care testing.  Our research team is currently working to integrate this 
immunosensor platform into our previously developed paper-based analytical device [39]. 
Continued development of this novel platform technology can greatly increase the capacity of 
public health agencies worldwide to assess drug or vaccine efficacy and to monitor emerging 
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CHAPTER 6: CONCLUSION 
 
 
Over the past several decades, different aspects of pathogen-detecting platforms have 
been extensively studied in a massive effort to achieve true point-of-care diagnostic capability. 
The World Health Organization established the ASSURED criteria for truly point-of-care 
platforms. This acronym stands for Affordable, Sensitive, Specific, User-friendly, Rapid and 
robust, Equipment-free and Delivered to these in need [1]. Despite recent technological 
advances, the development of such platforms meeting the ASSURED criteria remains elusive. In 
this dissertation, the platforms for microorganism detection, including whole microorganism 
separation, nucleic acid and antibody sensing, have been constructed, validated and applied to 
clinical related samples under the guidance of the ASSURED criteria.  
6.1 Conclusions from Chapters 2 and 3 
A passive approach for inertial focusing of micron and submicron-sized particles and 
bioparticles with high throughput has been systemically studied to sort microorganisms. Besides 
microorganism enrichment and separation, there are a broad set of potential applications for this 
platform, such as isolating subcellular organelles, monitoring heterogeneous responses of 
bacteria in drug susceptibility testing, and observing signals of bacteria and subcellular 
organelles in miniaturized cytometry and digital microfluidics.  
In addition, efficient inertial focusing of nano-scale particles/bioparticle, e.g., virus and 
DNA, is still waiting for exploration and exploitation. However, reducing channel size, as what 
we did in chapters 2 &3, may not be enough to achieve this goal alone. Introductions of 
additional active manipulation techniques and viscoelastic forces into the current platform could 
be explored.  
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The current theory of inertial focusing is feasible to guide experimental explorations on 
the effects of altering channels dimensions and operation conditions for specific sizes or shapes 
of particles, but the lack of the ability to accurately predict the outcomes of a proposed 
experiment still eludes researchers. Therefore, the optimization of microchannels designs for 
broader biomedical applications using numerical simulations is one of the intriguing areas for 
future research. More efforts are still needed to uncover the detailed underlying mechanism of 
inertial focusing and provide explicit guidelines for point-of-use applications to the end users 
without backgrounds on inertial microfluidics.  
The works presented in chapters 2&3 in this dissertation are fundamentally two 
dimensional (2D) focusing. Only two focal positions on a 2D plane were achieved, due to the 
limitations on channel geometries imposed by the fabrication technique used.  Three-dimensional 
(3D) printing technology has demonstrated capacities toward design and fabrication 3D structure 
in an inexpensive and rapid manner. Integration of 3D printing technique with inertial 
microfluidics could be promising for rapid production of three dimensional microchannel, for 
example, vertical tightly curving loops and the alternation of horizontal and vertical straight 
sections [2]. Such structures are able to provide an additional focusing dimension to realize 3D 
particle inertial focusing. 
In conclusion, significant progress has been made for inertial microfluidics in the past 
decade towards high-throughput, low-cost, and wide applications, but a wide range of raw 




6.2 Conclusions from Chapters 4 and 5 
To directly test nucleic acid and anti-pathogen antibody in an ultra-sensitive way, 
capacitive based affinity sensors have been built and tested with clinically relevant samples. Both 
the DNA sensor and immunosensor designs can be easily integrated with microfluidics and 
handheld measurement devices to make them suitable for field work and point of care testing. 
Furthermore, the widely-used smartphones are presenting unprecedent opportunities toward 
point of care detection of pathogen in a low-resource setting. Adaptable connectors for 
smartphone are therefore worthwhile to be further explored for the DNA and antibody detection 
platforms developed in chapters 4&5.   
The ability to perform multiplexed tests can be explored through integrating parallel 
testing units, which is especially important for the detection of pathogens that have similar 
infection symptoms. Parallel multiplexing is also able to reduce detection costs by providing 
multiple information from a single-shot analysis.  
Furthermore, these sensors can be constructed as paper-based analytical devices, which 
would further cut the cost of detection largely but still retain good sensitivity and specificity. 
Further studies should also explore the stability of the devices under a wide range of conditions, 
such as storage, transport, and clinical administration.  
In order to bring microsystems developed in laboratory conditions to commercial market, 
strong collaborations between academia and industry are needed to address the key issues, such 
as the reproducibility. As reported, it is common to have the device-to-device variabilities due to 
the techniques of fabrication and electrode modification used in the laboratory [3]. The 
commercialized screen printing of electrodes can provide improved biosensor reproducibility in 
large scale productions. Companies producing commercially available screen-printed electrodes, 
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including Metrohm USA Inc., DropSens S.L., and Bio-Logic SAS [4], are able to bridge this 
gap. 
Possible future applications of the developed DNA and antibody detection platforms 
include, but are not limited to, pathogen detections. For instance, these devices could be 
expanded to non-invasive diagnostics of Down syndrome and other aneuploidies through the 
blood sample of pregnant women containing DNA from their fetus; it is also promising to adapt 
the developed antibody sensor to monitor the status of the immune system by sensing the 
repertoire of expressed antibodies, which could provide a detailed picture of the various 
processes of immune defense. 
Continued developments of these novel platforms can greatly increase the capacity of 
public health agencies worldwide to assess drug or vaccine efficacy and to monitor emerging 
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APPENDIX I: SUPPLEMENTARY INFORMATION FOR CHAPTER 5 
 
 
7.1 Preparation of plasmids for Zika DNA immunization. 
Genes for the Zika virus PRVABC59 strain (NCBI Accession: KX087101) capsid and 
prM-Env proteins were codon-optimized for mammalian expression and synthesized by 
Genescript Inc.  The V5 epitope tagged capsid gene was cloned into the EcoRV site of 
pcDNA3.1 (plasmid pBG610), and a Japanese encephalitis virus prM signal sequence was added 
to the prM-Env gene and the construct was cloned into the EcoRV site of pcDNA3.1 (pBG611) 
as previous described 1. Plasmid sequences will be provided upon request. Expression of capsid 
and prME proteins after transfection into Vero cells was verified by Western blot analysis using 
anti-V5 (Life Tech) and anti-Envelope (4G2 2(ATCC HB-112 (D1-4G2-4-15))) antibodies, 
respectively (data not shown).   
DNA was prepared for immunization using the TempliPhi Rolling Circle Amplification 
Kit (GE HealthCare) according to the manufacturer’s instructions.  DNA was purified by 
phenol:chloroform extraction and ethanol precipitation, quantified by UV spectrometry, and 
stored at -20oC until DNA immunization.  Equal molar amounts of each amplified DNA were 
prepared in saline at 2μg total DNA/50μl or 10μg total /50μl prior to immunization.  
7.2 Ethics Statement. 
This study was carried out in strict accordance with the recommendations in the Guide 
for Care and Use of Laboratory Animals of the National Institutes of Health. The protocols were 
approved by the Institutional Animal Care and Use Committee at the Colorado State University 
(Assurance Number: D16-00345) under IACUC protocol number 16-6565A. Every effort was 
taken to minimize pain and suffering in the animals.   
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7.3 DNA Immunization. 
Ten 6-week old female CD1 outbred mice were purchased from Jackson Laboratories for 
use in DNA vaccination studies. Pre-immune sera were collected from each mouse via 
submandibular vein punctures, and five mice (Mice 1-5) were immunized intramuscularly with 
4μg total DNA (50 μl of 2μg/50μl in each flank (Mice 1-3)) or 20 μg total DNA (50μl of 
10μg/50μl in each flank (Mice 6-10)).  100 μl of whole blood was collected via retro-orbital 
bleed at Days 4, 7, 14, and 21 post-immunization. At Day 28 post-immunization, mice were 
anesthetized with isoflurane and terminal bleeds were collected via cardiac puncture.  Sera was 
separated from whole blood via centrifugation at 13K RPM, and clarified sera were stored at -
20oC in single-use aliquots until use. 
7.4 Initial Assessment of IgG Antibody in Immunized Sera via Western Blot and ELISA.   
Aliquots of Day 21 sera from Mice 1-10 were used as the source of primary antibodies in 
strip Westerns. Vero cells infected with the PRVABC59 strain of Zika virus 3 were lysed in 
Laemelli buffer and resolved on 12% PAGE gels.  Proteins were transferred to nitrocellulose 
membranes that were subsequently cut into strips.  Strips were blocked in phosphate-buffered 
saline 0.05% Tween + 2% non-fat dried milk (PBST-NFDM), then incubated in PBST-NFDM 
with each sera (1:100 dilution) overnight.  10 µg/mL of 4G2 antibody was used as a control.  
Strips were washed with PBST, incubated with anti-mouse IgG HRP (abcam# ab6728) in PBST-
NFDM for 1 hr, washed with PBST, and developed with Pierce 1-step Ultra TMB-blotting 




Fig. S5.1.  Western blot analysis of IgG antibody responses in mice immunized with Zika DNA 
vaccine. * denotes the presence of anti-Zika envelope reactivity in Day 21 samples. 
 
An ELISA assay was used to determine the relative amounts of IgM and IgG in the 
Mouse 3, 4, and 6 Day 4 and Day 21 serum samples.  Briefly, 100 µL of 10 µg/mL ZIKV E 
protein (My Biosource Cat# MBS319787) diluted in PBS (pH 7.4) was added to each well of a 
Nunc Maxisorp 96 well plate (Cat# 44-2404-21) and incubated at 4˚C overnight.  Excess antigen 
was discarded and the wells were washed three times with 0.05% PBST (pH 7.4).  300µL of 
fresh blocking buffer (4% milk powder in PBS) was then incubated in each well for 1 hour at 
room temperature.  Afterwards, the wells were washed six times with 0.05% PBST.  100 µL of 
mouse serum was then incubated for 1 hour at room temperature at dilutions of 1:100, 1:500, and 
1:2500.  10 µg/mL of 4G2 antibody was used as a positive control.  The wells were washed 
again six times with 300µL of 0.05% PBST and 100 µL of 1:3000 HRP-conjugated anti-mouse 
IgG (AbCam ab97023) or IgM (AbCam ab97230) was incubated for 1 hour at room temperature.  
The plate was washed six times with 300 µL 0.05% PBST then again twice with 300 µL of PBS 
to eliminate residual detergent.  100 µL of TMB-ELISA substrate (ThermoScientific) was 
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incubated for 30 minutes at room temperature and quenched with 100 µL of H2SO4.  Absorbance 
was measured at 450 nm.  Results of the ELISA assay are shown in Supplementary Figure 5.3. 
 
 
Fig. S5.2. Capacitive responses of pre-immune and Day 4 after ZIKV infected mouse serums at a 
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